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ABSTRACT
Mono-ADP-ribosyltransferases, which have activities similar to bacterial
exotoxin ADP-ribosyltransferases, have been identified in a variety of tissues. Few
have been purified to homogeneity and of these arginine specific cholera toxin-like
ADP-ribosyltransferases are most common. In this thesis the purification and
characterisationofa cysteine specific pertussis toxin-likemono-ADP-ribosyltransferase
is reported. This protein was purified on the assumption that, like pertussis toxin, the
enzyme would be able to use free cysteine as an acceptor for ADP-ribose in the
absence of its protein substrate. A cysteine specific ADP-ribosyltransferase activity
was found in bovine erythrocytes. A three step purification procedure was developed
involving (1) precipitation with 40 % ammonium sulphate, (2) binding to a cysteine
Sepharose affinity column, and (3) binding to a NAD+ affinity column.
Polyacrylamide gel electrophoresis showed a single band at 45,000. The enzyme had
been purified 47000 fold and had a specific activity of 1900 nmol nicotinamide
released min1 mg"1. A study of the kinetic properties of this enzyme showed that
apparent substrate kinetics for cysteine were observed (Km of 4.4 mM) and a putative
ADP-ribosyl-cysteine product was identified by HPLC. The ability of this enzyme
to ADP-ribosylate protein was investigated using re-sealed inverted bovine erythrocyte
ghosts. Incubation of the purified enzyme with erythrocyte ghosts and [adenylate-
32P]NAD+ led to the enhanced labelling of a 55 kDa protein identified by
autoradiography of separated proteins on SDS-polyacrylamide gels. Pertussis toxin
also caused enhanced labelling of this 55 kDa protein as well as labelling of a 42 kDa
protein, Qa. The 55 kDa protein was not recognised by antibodies raised against Q
orGs and has not been identified. However evidence that mono-ADP-ribosylation of
a cysteine residue on this 55 kDa protein had been catalysed was supported in three
ways. (1) the labelling was blocked by pre-treatment of the erythrocyte ghosts with
N-ethylmaleimide (NEM), a sulphydryl alkylating agent. (2) the labelling was
insensitive to hydroxylamine, but was released by mercuric ion, and (3) the released
radiolabeled product was identified as ADP-ribose on HPLC.
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NAD+ dependent ADP-ribosylation of cellular proteins is an important post-
translational modification by which protein structure and function may be altered.
Two classes of ADP-ribosylation reaction occur, poly-ADP-ribosylation and mono-
ADP-ribosylation. These reactions differ not only in the chain length of the ADP-
ribose units, but also with respect to the chemical nature of the glycosidic linkage, the
enzymes involved and the site of reaction.
Poly-ADP-ribosylation is primarily associated with the eucaryotic nucleus and
has an important role in regulation of nuclear events, eg DNA repair, chromatin
organisation, cellular differentiation and proliferation1. The work presented in this
thesis however is concerned with mono-ADP-ribosylation. Mono-ADP-
ribosyltransferase activity was first discovered during the study of the action of some
bacterial protein exotoxins and has been known for some time. These systems have
been well characterised. Study of the action of these bacterial toxins on eukaryotic
cells indicated that endogenous mono-ADP-ribosylation existed. Indeed mono-ADP-
ribosylated protein predominated by far over poly-ADP-ribosylation in mammalian
cells outside of the nucleus. It is only recently that endogenous mono-ADP-
ribosyltransferases have been purified from eukaryotic cells, however the physiological
role of these reactions is poorly understood.
Mono-ADPribosyltransferases (E.C. 2.4.2.30 and E.C. 2.4.2.31) catalyse the
transfer of a single ADP-ribose unit from NAD+ to an acceptor site on a target
protein with the concomitant release of nicotinamide and a proton:
NAD+ + protein « ADP-ribosyl-protein + nicotinamide + H+
The bacterial exotoxins studied are specific for a particular amino acid of a
particular target protein. The endogenous enzymes purified to date also appear to be
site and target specific. ADP-ribosylation of arginine residues have been most
commonly reported, but modification of lysine, asparagine, modified histidine
(diphthamide) and cysteine residues are also observed. Many of the bacterial
exotoxins studied in detail exert their action on a single family of GTP binding
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proteins, the G proteins. It is remarkable that entirely different organisms should each
secrete an enzyme activity, for which no endogenous role has been attributed within
the bacterial metabolism, which can modify a related family of proteins in eucaryotic
cells by apparently similar molecular mechanisms. Structure function studies of these
enzymes shows very little homology at the amino-acid level although essential
catalytically active residues are conserved. Crystal structures of some of the bacterial
toxins have been resolved, and it is speculated that a NAD+ binding groove is
common to all ADP-ribosylating toxins. Endogenous mammalian enzymes which
apparently catalyse the same reaction have been identified, but the extent of
knowledge of these enzymes is very limited. Much of the data concerning
endogenous mammalian ADP-ribosylation comes from identification of ADP-
ribosylated proteins after various stimuli, eg hormones, nitric oxide or nutritional
stress. ADP-ribosylation is observed in a variety of cells and the target proteins are
found in a variety of cellular compartments, eg nucleus, mitochondria, cytosol,
plasma-membrane or cytoskeleton. ADP-ribosylation has been associated with a
variety of biological processes involving receptor-mediated signal transduction Ca2+
signalling and growth and differentiation. How ADP-ribosylation is switched on or
off is not clear. Reversible ADP-ribosylation as a mechanism for controlling
metabolism has been demonstrated in a prokaryotic system. Enzymes which
specifically cleave ADP-ribosyl-protein have been purified from mammalian cells,
which allows for a reversible control mechanism.
1.1 Bacterial Protein Exotoxins
Mono-ADP-ribosylation was first identified on discovery of the mechanism of
action of diphtheria toxin twenty five years ago2. Diphtheria toxin is secreted by
Corynebacterium diphtheriae and is the causative agent of the disease. The target of
the toxin is elongation factor 2 (EF-2) and its ADP-ribosylation results in inhibition
of protein synthesis. The site of ADP-ribosylation is a modified histidine residue
called diphthamide, which was identified by van Ness3. Mono-ADP-ribosylation was
also found to be of importance in the pathogenesis of cholera and whooping cough.
Cholera toxin is secreted by Vibrio cholerae and its intra-cellular target is the
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stimulatory component of adenylate cyclase, Gs. ADP-ribosylation of Gs results in
the permanent activation of adenylate cyclase such that cyclic AMP levels rise within
the cell and signal transduction is disrupted. Pertussis toxin, secreted by Bordetella
pertussis, has a similar effect on the cell. The cyclic AMP dependent signalling
transduction pathway is disrupted by the permanent activation of adenylate cyclase.
The target for ADP-ribosylation is the inhibitory component of adenylate cyclase Gs.
(This process is discussed in more detail in section 1.2.5.)
The examples sited above have been well characterised, mainly because of
their importance in the pathogenesis of the diseases caused by the organisms. Their
mechanism of action, their primary amino acid sequence and even their three
dimensional structures are known. In addition cholera toxin and pertussis toxin have
provided invaluable tools for studying the interaction ofhetero-trimeric G proteins and
receptor mediated signalling transduction pathways. Secretion of ADP-ribosylating
proteins is not limited to these pathogenic organisms. Many bacteria have been shown
to secrete ADP-ribosyltransferases, and these are listed in table 1.1 below. Some
have a similar action to those described above, eg pseudomonas exotoxin A and E.
coli heat labile toxin and others, eg botulinum C2 and C3, modify novel target
proteins. Clostridium botulinum secretes several neurotoxins, termed A,B,C1,D,E,F
and G which are all antigenically different. The ADP-ribosylating toxins C2 and C3
secreted by certain strains are distinct from the neurotoxins in that they do not block
secretion, instead they induce cellular morphological changes4. The substrate for C2
is monomelic actin. ADP-ribosylation of actin inhibits the ATP hydrolysing activity
(ATPase) of actin which is essential for polymeristion to actin filaments. The cellular
target for C3 is the small GTP-binding protein rho p21. C3 catalyses the transfer of
ADP-ribose from NAD+ to form a novel ADP-ribosyl linkage via an asparagine
residue of rho5.For t e purposes of this thesis the mechanism of action of pertussis
toxin will be discussed in more detail, and structural and functional similarities with
other toxins will be identified.
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Table 1.1 Bacterial ADP-ribosylating Toxins





Diphtheria toxin Elongation factor 2 diphthamide - 715
Pseudomonas Elongation factor 2 diphthamide - 715
exotoxin A
Pertussis toxin a subunit Q





































































Pertussis toxin is one of many proteins secreted by Bordetella , the
pathogenic bacterium causing whooping cough. It was first purified in 19786 and
identified as a 117 kDa protein by gel filtration chromatography. It was referred to
as islet activating protein (IAP) after its ability to enhance insulin secretion in
pancreatic islets of Langerhan cells7. Later it was termed pertussis toxin, reflecting
its importance as the major causative agent of whooping cough. ADP-
ribosyltransferase activity was first demonstrated as the mechanism of action of the
toxin in the early eighties8. ADP-ribosylation of a 41 kDa membrane protein was
observed in pancreatic islet cells and it was subsequently shown that a cysteine residue
was the site of modification9. This is the only bacterial toxin known to modify a
cysteine residue. In 1986 the cloning of the pertussis toxin operon was achieved
independently by two groups10'11 and little identity with other ADP-ribosylating toxins
was noted. The essential regions of the toxin required for activity were mapped and
this work paved the way for the development of acellular recombinant DNA derived
vaccines to replace the original whole cell preparations12.
1.2.1 Subunit Organisation
Pertussis toxin is a hexaemeric protein and follows the classical AB type model
of bacterial toxins13. It has an A protomer which is enzymatically active and a B
oligomer which is concerned with attachment and internalisation of the toxin into the
host cell. Pertussis toxin has the most complex subunit organisation of these AB type
bacterial toxins, in that it is made up of five different subunits. SI (28,000) catalyses
ADP-ribosyltransfer of ADP-ribose moiety from NAD+ to a target acceptor and is
discussed in more detail in section 1.2.3. The B oligomer is made up of four different
subunits S2, S3, S4 and S5 (23,000, 22,000, 11,700 and 9,300) in the molar ratio
1:1:2:1. Cholera toxin and E. coli heat labile toxin are also hexaemeric proteins,
however the B oligomer is made up of one repeating subunit.
The three dimensional crystal structure of E. coli heat labile enterotoxin
showed that the B oligomer forms a ring doughnut-like structure with the A protomer
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attached via an hairpin like structure, made up of the C-terminal residues 222-228,
which passes through the centre of the highly charged pore.14. E. coli heat labile
toxin is 80 % identical to cholera toxin at the amino acid level. Preliminary three
dimensional structures of cholera toxin appear to show similar subunit arrangement15.
The complex subunit composition of pertussis toxin made the assignment of the three
dimensional structure very challenging. Stein and Reed (Edmonton, Canada) have
succeeded16. On a structural level pertussis toxin looks like the cholera related toxins,
despite the lack of homology between their primary structures. The B oligomer forms
a ring structure with an internal diameter 11-15 A, too small for the A protomer to
pass through. The small C-terminal tail inserts into the centre of the ring, but unlike
the A protomer of cholera toxin plays little part in holding the B oligomer and A
protomer together. The SI subunit is held tightly associated to the B oligomer by
favourable interactions between SI and S2, S3, S4 and S5.
Diphtheria and related toxins on the other hand appear to be quite different.
Diphtheria toxin is secreted as a single poly-peptide which is "nicked" very easily by
host proteolytic enzymes to release an active protomer. The idea of separate domains
within the single poly-peptide is clearly visualised from the three dimensional crystal
structure17. Three domains are identified; domain I, receptor binding, domain II,
translocation, and domain III, enzymatic activity.
1.2.2 Binding Entry and Activation of Pertussis Toxin
The nature of the receptor site and mechanism of internalisation of the toxin
into the cell have not been well characterised. The current view on binding and entry
of pertussis toxin has been proposed by Kaslow and Burns18 and is shown in
Figure 1.1. Galactose glycoconjugate and sialic acid glycoconjugate recognition sites
have been identified in S2 and S3 subunits of the B oligomer which may serve to
anchor the toxin at the cell surface19. Two possible mechanisms for internalisation of
bacterial toxins have been proposed, endocytosis and direct penetration. An example
of a toxin which is enters by endocytosis is diphtheria toxin20. Cholera toxin is
thought to penetrate the membrane directly21 and it is thought that pertussis toxin
proceeds in a similar fashion. The molecular basis for this mechanism is not
understood.
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Binding —> Internalisation —> Dissociation —> Redution and catalytically active
Figure 1.1 A Simplified Model for Binding, Entry and Activation of Pertussis
Toxin.
Before ADP-ribosyltransferase activity is observed the toxin must undergo an
activation process which involves the release ofSI from the B oligomer and reduction
of an intra-molecular disulphide. Kaslow et al.22 proposed a model for activation in
which ATP and lipophilic substances bind to the whole toxin and promote the release
of SI which is then reduced and can exert its toxic effect on its protein target.
Cellular concentrations of ATP and glutathione would be sufficient to promote this
process such that host enzymatic machinery would not be required for the activation
process. The C-terminal tail of SI is highly hydrophobic and it is thought it might
anchor the SI to the membrane rather than allowing its release into the cytoplasm23.
The role of the B oligomer is not simply a carrier for targeting the ADP-
ribosyltransferase activity of SI. The B oligomer also has some intrinsic activity of
its own, independent of ADP-ribosylation, which are manifested in the disease state
eg lymphocytosis promotion, histamine sensitisation and haemagglutination24. In vitro
experiments with Jurkat T lymphocyte cell lines have shown increases in inositol
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phosphate and intra-cellular calcium concentrations on treatment with the B oligomer
alone25.
1.2.3 The SI Subunit
The SI subunit catalyses the transfer of ADP-ribose moiety from NAD+ to a
C-terminal cysteine residue of G.c*9 with the concomitant release of nicotinamide and
a proton. In the absence of the target protein the toxin may use water as an acceptor
for ADP-ribose. This abortive reaction is termed the NAD glycohydrolase activity
and is common to all the ADP-ribosylating toxins. This reaction is a useful tool for
studying the mechanism of the enzyme and is discussed in more detail in chapter four.
The amino-acid sequence of the SI subunit has been compared to the active
subunits of the other known ADP-ribosylating toxins10,11. Two regions, eight amino
acids each, showing significant homology can be identified between pertussis toxin,




E. coli LT A
00 Tyr Arg Tyr Asp
6 Tyr Arg Ala Asp
6 Tyr Arg Ala Asp
Ser Arg Pro Pro 15
Ser Arg Pro Pro 13




E. coli LT A
51 Val Ser Thr Ser
60 Val Ser Thr Ser
60 Val Ser Thr Ser
Ser Arg Ser Arg 58
Leu Ser Leu Arg 67
Leu Ser Leu Arg 67
These similarities at the amino acid level are not mirrored in the DNA
sequences as pertussis toxin uses different triplet codons to that of cholera toxin and
E. coliLT. No other sequence similarities were found between the toxins.
A putative "Rossman fold"26, the phosphate binding site of nucleotide binding
proteins, was identified in the C-terminal region of SI from the sequence motifG-X-
G-X-X-A27. However this region was found not to be essential for enzymatic activity
following the construction of deletion mutants. The C-terminal portion of SI, amino
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acids 181-23427, are not essential for enzymatic activity however ADP-ribosylation is
more efficient with whole SI28. This apparent differentiation of SI subunit into two
domains is similar to the differentiation of cholera toxin A protomer into A1 (N-
terminal, catalytically active) and A2 (C-terminal). Photoaffinity labelling
experiments with NAD+ identified an interaction with glu-12929. Comparable
experiments with cholera and diphtheria toxins also showed modification of a
glutamate residue. Substitution of glu-129 for glycine or aspartic acid residues by site
directed mutagenesis inactivated the toxin suggesting a catalytic role for this residue30.
Other important residues have been identified in the N terminal portion of the subunit
which probably have a role in binding ofNAD+: deletion or conservative substitution
of these aminoacids causes an increase in the affinity of binding NAD+ but has no
effect on the maximal rate of catalysis. These include amino acids tyr-8 to pro-1531
(region 1), trp-2632 and cys-4133.
These studies suggested that there may be a common NAD+ domain among
the ADP-ribosylating toxins. The resolution of the crystal structures of Pseudomonas
exotoxin A and E. coli LT support this idea34. Structural superposition of the
enzymatic domains showed significant structural similarity. This is remarkable given
the lack of sequence identity at the amino acid level. 44 residues, only three ofwhich
were identical from the central region of the molecule were superimposed upon one
another. These residues corresponded to tyr-6, ala-69 and glu-112 in E. heat
labile toxin.
1.2.4 Protein Substrates of Pertussis Toxin
The main protein substrate for ADP-ribosylation by pertussis toxin is Gb a
member of the heterotrimeric guanine nucleotide-binding protein family (G proteins).
G proteins act as switches that regulate infomation processing circuits connecting cell
surface receptors to a variety of effectors. The G proteins are present in all
eucaryotic cells, and they control metabolic, humoral, neural and developmental
functions. More than a hundred different receptors and many different effectors have
been described. The G proteins are made up of three different subunits a, 6 and y
(39 - 52 kDa, 35 kDa and 8 kDa respectively) that are derived from a large gene
family. This family contains at least sixteen different genes encoding the a subunit,
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four that encode the 8 subunit and multiple genes encoding the y subunit. Pertussis
toxin sensitive Ga subunits are characterised by a conserved C-terminal cysteine
residue and are listed in table 1.2.















Gsa LRQYELL - 37
Gaq, Gall LREFNLV - 37
Gj is involved in the regulation of adenylate cyclase, which generates the
important second messenger cyclic AMP, and is normally under the control of
inhibitory hormones. Adenylate cyclase is also under the control of a stimulatory
regulatory GTP-binding protein, Gs which is the substrate for cholera toxin. The
phospholipase C enzyme is another protein under the control of GTP binding
proteins38 which may be uncoupled from its receptor by the action of pertussis toxin.
Phospholipase C is important for the production of two second messengers - inositol
triphosphate and diacylglycerol, within the cell. These G proteins are known as Gp
and at least two forms exist, one of which is a substrate for pertussis toxin catalysed
ADP-ribosylation39. Transducin is closely related to Gi and is found in the outer rod
segments of the eye. Its role is to mediate signal transduction from the light receptor
rhodopsin to cGMP phosphodiesterase which raises the concentration of cGMP in the
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retinal rod cell resulting in the hyperpolarisation of the rod membranes and a change
in neurotransmitter release of the output synapse. Identification of the site of ADP-
ribosylation as the C-terminal cysteine residue was shown using purified transducin9.
Transducin is unusual in that it also a substrate for cholera toxin. G0 stimulates ion
channels in central nervous neurons. These include non-selective monovalent cation
channels, K+ selective but non-rectifying channel and receptor triggered (eg. opioid)
inhibition of presynaptic Ca2+ channels40. Muscarinic acetyl choline receptors are
members of the G protein super family, five subtypes have been identified of distinct
primary structure. M2 and M4 receptors are substrates for pertussis toxin41 and inhibit
adenylate cyclase activity. Mt, M3 and M5 receptors regulate inositol phosphate
turnover but are not substrates for pertussis toxin. They contain a C-terminal cysteine
but this is the site of palmitoylation42.
1.2.5 Pertussis Toxin and Receptor-Mediated Signal Transduction
The G-proteins are found on the cytoplasmic surface of the plasmamembrane.
The function of G proteins in receptor mediated signal transduction43,40 is depicted in
Figure 1.2. An agonist (eg adrenalin, acetylcholine, muscuranic acid) binds to its
receptor and produces a change in the receptor-G protein interaction, allowing GTP
to displace GDP on the a subunit. The activated GTP-a subunit has a low affinity
for the By subunits and dissociates. The free GTP-a associates with the effector (eg
adenylate cyclase, K+ channel, phospholipase C) and modifies its function. The a
subunit is able to hydrolyse the bound GTP to GDP (GTPase activity) with the release
of inorganic phosphate (Pi). a-GDP is released from the effector complex and re-
associates with By subunits, thus completing the cycle. Regulation of the effector
targets controls the concentration of second messengers within the cell, which in turn
regulate protein activity. Hence these cascade processes can control whole cell
activities such as muscle relaxation and contraction, dermotaxis, exocytosis and
endocytosis, energy metabolism, cell differentiation and proliferation.
Pertussis toxin catalyses the ADP-ribosylation of the a subunit, only in the
presence of the By complex44 and the reaction is inhibited by divalent cations45. The
ADP-ribosylated G proteins are then no longer capable of being coupled to their
receptors. This is a different mechanism to that catalysed by cholera toxin, in which
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cytosolic ADP-ribosylating factors (ARF) and divalent cations are required for ADP-
ribosylation. ADP-ribosylation ofGsa results in inhibition of its GTPase activity such
that the a subunit becomes permanently activated, which in turn permanently activates
adenylate cyclase and cAMP levels increase. Spontaneous and rapid accumulation of
cAMP, independent of any receptor stimulation can occur in cholera toxin treated cells
which can induce non specific effects independent ofG protein function. In contrast,
pertussis toxin uncouples the substrate G proteins from their receptors selectively and
there is no detectable change in cAMP levels in the absence of receptor stimulation46.
Pertussis toxin therefore, has provided a useful tool for studying the interaction of G
proteins in signal transduction.
Some of the clinical effects ofB. pertussis infection may be attributed to ADP-
ribosylation ofG proteins, for example, histamine sensitisation. When animals which
have been pre-treated with pertussis toxin are challenged with histamine, the normal
compensatory physiological response does not occur47. The pertussis toxin catalysed
ADP-ribosylation prevents the a-adrenergic (Rj) induced release of catecholamine and
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the histamine induced vasodilation is eventually fatal. Hypoglycaemia48 and islet
activating property49 of the pertussis toxin may also be explained as a result of
blockage of the a-adrenergic system which is responsible for inhibition of insulin
secretion.
1.3 Endogenous ADP-ribosylation
In the early eighties Hilz and coworkers studied in detail the distribution and
level ofpoly(ADP-ribose) and mono-ADP-ribose protein conjugates in Ehrlich ascites
tumour cells50, lymphocytes51, developing rat liver cells52 and rat liver subjected to
various nutritional and hormonal conditions53,54. Several important observations were
made. (1), Protein bound mono-ADP-ribose was present in several hundred fold
excess over poly(ADP-ribose) modified proteins. (2), Poly(ADP-ribose) modified
proteins were confined to the nucleus, whereas mono-ADP-ribosylated proteins were
present in a variety of cellular compartments. (3), Mono(ADP-ribose) proteins could
be further subdivided into hydroxylamine sensitive and resistant conjugates and these
have different cellular locations. (4), Hydroxylamine sensitive mono-ADP-ribose
conjugates were located in the endoplasmic reticulum and their levels correlated well
with cell growth rates. (5), Hydroxylamine resistant conjugates were localised
mainly in the mitochondria and also to some extent in the plasma membrane; their
levels correlated well with hormone stimulation and cellular differentiation. In these
experiments hydroxylamine sensitive conjugates refers to carboxyl ester linkages of
ADP-ribose with glutamate residues; the site of modification for poly(ADP-
ribosyljation of histone55. Hydroxylamine resistant conjugates included arginine
cysteine and diphthamide residues56.
In these studies cellular proteins were precipitated with trichloroacetic acid and
the total amount of ADP-ribosylated protein present was estimated from the amount
of radiolabel detected in the acid insoluble fractions. This technique was highly
sensitive to trapping of NAD+ which may have lead to over estimation of the total
levels of ADP-ribosylated protein. However these results were confirmed, using a
more sensitive technique developed by Jacobson et al.51, based on fluorescent
detection of released adenine containing derivatives after selective adsorption of
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polymeric and monomelic ADP-ribose onto a boronate resin. Mono-ADP-ribosylated
proteins have been classified according to the type of linkage between ADP-ribose and
the protein. The chemical stability of glutamate-, arginine-, cysteine-, asparagine-,
lysine- and diphthamide-ADP-ribose has been studied and can be used to identify the
type of modification without knowing the amino-acid sequence. This is discussed in
more detail in chapter five. The amount of mono-ADP-ribose modified carboxylate,
arginine and cysteine present in rat liver invivo have been estimated to be similar at
16, 19 and 14 pmol/mg protein respectively58.
1.4 Endogenous mono-ADP-ribosyltransferases
The study of endogenous mono-ADP-ribosylation has been approached in two
ways. The first is a direct approach where the enzymes responsible have been isolated
and characterised. The properties of the endogenous ADP-ribosyltransferase, its
substrates, factors which effect its activity and its distribution are all important for
understanding the possible role of these enzymes in the cell. Several endogenous
ADP-ribosyltransferases have been isolated to date and may be classified according
to the type of ADP-ribosyl-amino acid linkage formed. These are listed in table 1.3
and will be discussed in turn. The second approach is indirect. Here the target
proteins which are modified in response to external factors are identified and the
cellular responses to the appearance of ADP-ribosylated protein noted. These
experiments clearly suggest a role for mono-ADP-ribosylation in intracellular
signalling. Some of the properties observed are listed in table 1.4 and the possible
biological roles will be discussed. These whole cell studies are complex systems, and
quite how mono-ADP-ribosylation interacts with the known intracellular signalling
pathways is not clear. A full understanding of the mechanism may require the
combination of the direct and indirect approaches in wjiich purified ADP-
ribosyltransferases are reacted with purified target proteins within a defined
reconstituted system.
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arginine unknown unknown 59
Rabbit Skeletal
Muscle
arginine unknown unknown 67








Hamster Kidney diphthamide EF 2 Inhibition of
Protein Synthesis
78
Beef Liver diphthamide EF 2 Inhibition of
Protein Synthesis
79
Rat Brain unkown actin Cytoskeleton 81
1.4.1 NAD+:Arginine ADP-ribosyltransferase
1.4.1.1 Turkey Erythrocytes
Endogenous NAD+:arginine ADP-ribosyltransferases have been purified from
a variety of sources. The first to be reported were from turkey erythrocytes59. A
total of four ADP-ribosyltransferases designated A, B, C and D were isolated from
this source60. Transferase A and B were soluble whereas transferase C and D were
membrane associated. Transferase A was purified 544,000 fold turkey erythrocytes
and had a Mr of 28,000 on SDS-polyacrylamide gels59. Transferase B was purified
270,000-fold and had a Mr of 32,000 on SDS-polyacrylaipide gels61. Transferase A
differed in two respects. First it was observed that the protein was converted from
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an inactive oligomeric form to an active monomeric form by the addition of salt62.
Second, Transferase A was able to use NADP+ as well as NAD+ as a substrate63.
Like cholera toxin, transferase A and B can catalyse the transfer of ADP-ribose to a
small guanidine containing compound eg agmatine. Detailed kinetic analysis of this
reaction was carried out and the data was consistent with a rapid equilibrium random
sequential mechanism in which the binding of the first substrate reduced the affinity
of the second by more than 70 %64. Purified transferase A did not activate adenylate
cyclase from turkey erythrocytes or any other source65. It did however possess ADP-
ribosyltransferase activity and catalysed the transfer of ADP-ribose onto an active site
arginine of glutamine synthetase66.
1.4.1.2 Skeletal Muscle
ADP-ribosyltransferase activity was detected in sarcoplasmic reticulum from
pig and rabbit skeletal muscle and sarcolemma from pig skeletal muscle67 using small
guanidine containing compounds as acceptors for ADP-ribose68. The enzyme
responsible is an integral membrane protein and is stimulated by detergents,
nucleotides, thiol reagents and magnesium ions. ADP-ribosylation of a number of
acceptor proteins in skeletal muscle was noted. In the sarcoplasmic reticulum ADP-
ribosylation of 100-110 kDa and 63-67 kDa proteins was observed. In the
sarcolemma several proteins were labeled 205 kDa, 110 kDa (major band), 63 kDa,
54 kDa, 38 kDa and 27 kDa. Two proteins were also labelled in the glycogen pellet
83-85 kDa and 63-67 kDa. No direct correlation between the arginine specific ADP-
ribosyltransferase identified and the ADP-ribosylation of the proteins observed was
made. However evidence that all of the above modifications were due to mono-ADP-
ribosylation of an arginine residue came from the fact that the labelling was inhibited
by the presence of L-arginine methylester (an alternative substrate); the labelling was
sensitive to hydroxylamine treatment and 5' AMP was released from the protein after
treatment with phosphodiesterase69. Later experiments showed that the 100 kDa
protein may be a subunit of Ca2+ ATPase (this is discussed in section 1.5.3).
Recently this membrane associated arginine specific ADP-ribosyltransferase
was purified 215,000-fold from rabbit skeletal muscle70 and tryptic peptides were
purified and characterised. The amino acid sequences obtained were then used to
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generate an oligonucleotide primer which was used in a polymerase chain reaction
(PCR) based procedure to generate cDNA. A probe was designed from the PCR
sequence and used to screen the rabbit skeletal muscle cDNA sequence library. A
molecular clone was identified and expressed in E. coli but ADP-ribosyltransferase
activity was not shown. The sequence obtained was novel and did not share any
sequence identity with the known bacterial protein toxins. This is the first and only
eucaryotic NAD+: arginine ADP-ribosyltransferase to be characterised at the
molecular level.
1.4.1.3 Hen Liver Nuclei
An NAD+: arginine ADP-ribosyltransferase was purified from hen liver nuclei
50,000 fold71. The purified protein appeared as a 27.5 kDa protein on SDS-
polyacrylamide gels. Agmatine, arginine, histones and casein could all serve as
acceptors for ADP-ribose. The enzyme activity was inhibited by phosphate and
chloride ions and did not require DNA. The ADP-ribose-histone adducts formed by
the enzyme served as initiators for poly(ADP-ribosyl)ation. Phosphorylation of
histones by c AMP-dependent protein kinase is inhibited by ADP-ribosylation72. This
may be explained by the fact that the site of ADP-ribosylation (arg-34) is close to the
site of phosphorylation (ser-38)73. The ability of the ADP-ribosyltransferase to
inhibit phosphorylation of other proteins was investigated and was demonstrated for
phosphorylase kinase74. ADP-ribosylation of purified phosphorylase kinase by the
purified ADP-ribosyltransferase was achieved and subsequently shown to inhibit
incorporation of phosphate onto phosphorylase kinase. The physiological relevance
of these experiments is debatable, because the ratios of protein substrate, NAD+ and
enzyme used were non-physiological, and the substrate protein is a cytosolic protein
and therefore is unlikely to come into contact with a nuclear enzyme.
1.4.2 NAD+: Cysteine ADP-ribosyltransferase
A NAD+: cysteine ADP-ribosyltransferase activity was purified from human
erythrocytes 35,000-fold and appeared as a single band 28,500 Da on SDS-
polyacrylamide gels75. Like pertussis toxin the enzyme was able to catalyse the
transfer of ADP-ribose from NAD+ to free cysteine; Km values of 65 /*M and 4.4 mM
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for NAD+ and cysteine respectively were determined. Detailed kinetic analysis of this
reaction suggested that a sequential, rapid equilibrium random order mechanism was
followed, similar to that of the NAD+: arginine ADP-ribosyltransferase64 described
in section 1.4.1.1. Protein ADP-ribosyltransferase activity was demonstrated using
inside out erythrocyte sealed membranes76. Labelling of a 41 kDa protein identical
to that labelled by pertussis toxin was observed. Pre-incubation of the membranes
with NAD+ and pertussis toxin inhibited the amount of labelling observed with the
purified endogenous enzyme, suggesting that the sites of ADP-ribosylation were
mutually exclusive, if not identical. The chemical stability of the endogenous
labelling and that catalysed by pertussis toxin were similar, ie they were both resistant
to hydroxylamine. The possible biological relevance of this endogenous activity was
demonstrated in platelet membranes77. Adrenalin, an ^-adrenergic receptor agonist,
inhibits adenylate cyclase activity in platelet membranes. Prior treatment of the
membranes with [32P]NAD+ and purified enzyme lead to labelling of 41 kDa
membrane protein and attenuation of the receptor mediated inhibition of adenylate
cyclase.
1.4.3 Other Endogenous ADP-ribosyltransferases
Mono-ADP-ribosyltransferases which modify elongation factor-2 (EF-2) have
been isolated from polyoma virus-transformed baby hamster kidney78 and normal
tissue from beef liver79. The endogenous enzyme catalysed reaction is much slower
than diphtheria toxin fragment A, but the extent of ADP-ribosylation was similar.
The endogenous enzyme was inhibited by histamine and antibodies raised against the
protein identified two proteins 80 kDa and 100 kDa by immuno-blotting.
In rat brain four major polypeptides are ADP-ribosylated by endogenous ADP-
ribosyltransferases corresponding to 20, 42, 45 and 50 kDa proteins on SDS
polyacrylamide gels80. Four ADP-ribosyltransferase activities, of which one catalysed
the ADP-ribosylation of actin, were partially purified from rat brain by separation on
carboxymethyl-sepharose and concanavulin A columns81. ADP-ribosylation of actin
was demonstrated using a two dimensional gel electrophoresis system which clearly
resolved actin from Gsa subunit. The type of linkage or the factors which affect the
ADP-ribosylation reaction have not been determined.
1.5 Biological role for mono-ADP-ribosylation
19
Evidence for mono-ADP-ribosylation of a variety of cellular target proteins in
a variety of tissues is observed, suggesting a ubiquitous role in cellular metabolism.
Not all of the target proteins have been identified. It is not clear whether all of the
modifications reported require an ADP-ribosyltransferase to catalyse the reaction, or
if they may proceed non-enzymatically.
If ADP-ribosylation is to play a role in cellular control mechanisms then it
may be expected that the ADP-ribosylation modification will be reversible. As will
be discussed in the following sections, the levels of ADP-ribose modified protein can
vary in response to a stimulus. Assuming that the levels of target protein are
unchanged then a reversible modification process is suggested. This mechanism has
been demonstrated in a prokaryotic system which is described in section 1.5.1.
Further evidence that such a system occurs in eucaryotes is mounting, as enzymes
which can hydrolyse ADP-ribosyl-arginine82 and ADP-ribosyl-cysteine83 have been
partially purified.
1.5.1 Reversible ADP-ribosylation Control Mechanism
The conversion of atmospheric nitrogen to ammonia by nitrogen fixing
organisms is catalysed by the nitrogenase complex, which consists of two electron
transferring proteins, dinitrogenase and dinitrogenase reductase. Reduction of N2 to
ammonia is an energy demanding process for which 20-30 ATP molecules are
hydrolysed per N2 reduced. It is therefore essential that the organism has an efficient
control mechanism to regulate nitrogenase activity.
Kanemoto and Ludden84 correlated the loss of whole cell nitrogenase activity
in Rhodospirillum rubrum, upon addition of ammonia with the covalent modification
of dinitrogenase reductase. Dinitrogen reductase activity is inhibited by the ADP-
ribosylation of an arginine residue situated three residues away from an iron-sulphur
centre, which blocks electron transfer85. ADP-ribosylation of dinitrogen reductase is
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Table 1.4 Evidence for Mono-ADP-ribosylation Control Mechanisms

































































catalysed by dinitrogenase ADP-ribosyltransferase (DRAT). Dinitrogenase is
activated by a dinitrogenase activating glycohydrolase (DRAG) which hydrolyses the
ADP-ribosyl-dinitrogenase linkage86. The genes encoding these modulating proteins,
draG and draT were identified and expressed in Klebsiella pneumoniae*1, an enteric
N fixing organism which does not normally express this ammonium switching
mechanism. Expression of draT and draG genes in K. pneumoniae allowed reversible
ADP-ribosylation of dinitrogenase to be correlated with inhibition of nitrogenase
activity in response to ammonia. These experiments provide direct evidence that
reversible ADP-ribosylation is a valid control mechanism in vivo.
1.5.2 ADP-ribosylation and Receptor-Mediated Signal Transduction
1.5.2.1 ADP-ribosylation of stimulatory component of adenylate cyclase
Evidence that Gs function is modified by endogenous ADP-ribosylation, and
is not unique to the action of cholera toxin is supported by work with rat hepatocytes
and cultured bovine thyroid cells. In these systems changes in the level of ADP-
ribosylation were observed in response to hormones, and endogenous ADP-
ribosylation of Gs could be correlated with the activation of adenylate cyclase. A
cholera-like endogenous activity was found in rat hepatocytes, in which a 55 kDa
plasma membrane protein was ADP-ribosylated88. Endogenous ADP-ribosylation of
this 55 kDa acceptor was stimulated by the action of the hormone isoproterenol in a
concentration dependent manner, and adenylate cyclase activity was also stimulated.
The effects were inhibited by the 8-adrenergic antagonist popranolol, suggesting that
the 55 kDa protein was the stimulatory regulatory subunit of the adenylate cyclase
system, Gs.
Thyrotropin (TSH) regulation of thyroid function is mediated via adenylate
cyclase stimulation. The properties of TSH stimulation of cultured bovine thyroid
cells was investigated89. ADP-ribosylation of a 40 kDa membrane protein was
observed after stimulation by TSH, which appeared to be identical to the major ADP-
ribosylated protein in the presence of cholera on SDS polyacrylamide gels. Like
cholera toxin the endogenous enzyme was able to use arginine methylester as an
acceptor for ADP-ribose. The kinetics of ADP-ribosyltransfer to the membrane
protein and artificial acceptor were compared and found to be similar90. Both
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reactions had a low affinity for NAD, Km of 0.4 mM and pH optima pH 7-7.5. The
similarity of the kinetics of each reaction suggest that they are catalysed by the same
enzyme. Purification of the ADP-ribosyltransferase was not achieved. Arginine
specific ADP-ribosyltransferase which have been purified from turkey erythrocytes did
not ADP-ribosylate Gs (section 1.4.1.1. ), which perhaps questions the validity of
assuming that ADP-ribosylation of Gs and artificial substrates in crude membrane
fractions are linked.
1.5.2.2 ADP-ribosylation of the Inhibitory Component of Adenylate Cyclase
There are only a few reports of endogenous ADP-ribosylation of cysteine
residues in the literature. It was only recently that a protocol for identifying ADP-
ribose-cysteine-protein was available58. Some of the early reports of endogenously
labelled proteins which were found to be resistant to hydroxylamine may have been
due to mono-ADP-ribosylation of cysteine residues. Several groups have observed
endogenous pertussis-toxin like activity. Rat islets of Langerhans cells are able to
ADP-ribosylate a 41 kDa membrane which is apparently identical to a pertussis toxin
labelled substrate, the inhibitory regulatory protein of adenylate cyclase, G91.
Endogenous ADP-ribosylation ofGj in human erythrocytes has been well characterised
(section 1.5.2.). Endogenous enzymes which catalyse the addition75 and removal77,83
of the ADP-ribose moiety onto Gj have been isolated from this source and reversible
ADP-ribosylation of G, has been demonstrated in vitro. ADP-ribosylation of G, was
stimulated by a adrenergic receptor agonist, adrenalin and de-ADP-ribosylation was
stimulated by micro-molar concentations of free calcium.
1.5.3 ADP-ribosylation and Calcium
The intracellular distribution of calcium and in particular the level of free Ca2+
are extremely important in the regulation of cellular processes eg metabolism,
fertilization, exocytosis, membrane transport smooth muscle contraction, sensory
perception, neuronal signalling and cell division92. Complex spatiotemporal patterns
of calcium waves and oscillations are generated within the cell from the selective
release of calcium from intracellular stores through tightly regulated calcium channels.
Cells have two intracellular channels for regulating calcium release from internal
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reservoirs; one under the control of the ryanodine receptor and the other regulated by
the inositolphosphate receptor.
1.5.3.1 Ca2+-dependent ADP-ribosylation
ADP-ribosylation of proteins has been linked in two ways with calcium. The
first is a cascade response to free Ca2+ in which calcium can effect which proteins are
ADP-ribosylated in a system. This was observed in rat adipocyte membranes93. In
the presence of calcium and NAD+ a 70 kDa protein was labelled, in the absence of
calcium however three proteins were labelled of 65 kDa, 61 kDa and 52 kDa. The
second example is where ADP-ribosylation of membrane proteins alters the level of
cellular calcium.
1.5.3.2 ADP-ribosylation of Ca2+ ATPase
The active transport of calcium from the cytoplasm into the sarcoplasmic
reticulum occurs at the expense of ATP hydrolysis through Ca2+ dependent ATPase.
Direct modification of Ca2+ dependent ATPase from rabbit muscle has been
reported94, using a reconstituted system containing partially purified Ca2+-dependent
ATPase and ADP-ribosyl transferase purified from rabbit skeletal muscle.
Modification of the 105 kDa subunit of the Ca2+-dependent ATPase was observed on
SDS polyacrylamide gels and could be correlated with the inhibition of its ATPase
activity. These experiments suggested that ADP-ribosylation of the sarcoplasmic
reticulum may play a role in the regulation of Ca2+ in skeletal muscle. The most
pronounced effects however have been observed in rat liver mitochondria. ADP-
ribosylation of two major mitochondrial proteins has been reported95. The first is a
50 kDa protein found in the mithochondrial matrix and the second is a 31 kDa protein
located on the inner surface of the inner mitochondria membrane that has been
associated with Ca2+ eflux from the mitochondria.
1.5.3.3 Enzymatic versus non-enzymatic ADP-ribosylation in Rat Liver Mitochondria
There is however some debate as to whether the apparently specific ADP-
ribosylation of mitochondrial proteins are true ADP-ribosyltransferase reactions as the
proteins could also be modified by free ADP-ribose96. NAD+ concentrations in the
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mitochondria are very high (1-2 mM) and NAD glycohydrolases have been located
and purified from the inner surface of inner mitochondrial membrane97. Richter et
al.9S proposed that Ca2+ eflux from the mitochondrion in response to oxidation and
hydrolysis of pyridine nucleotides was linked to ADP-ribosylation of the 31 kDa
protein, a putative Ca2+/H+ anti-porter . Evidence that ADP-ribosylation of the
31 kDa protein was catalysed by an ADP-ribosyltransferase was presented by
Masmoudi and Mandel", who separated the NAD glycohydrolase activity away from
ADP-ribosyltransferase activity contained in solubilised mitochondrial membranes by
a two step chromatographic procedure.
1.5.3.4 Cyclic ADP-ribose and Ca2+ Mobilisation
Most recently intracellular Ca2+ mobilisation in cells has been linked with a
cyclic intermediate of NAD+100, the structure of which has been identified as cyclic
ADP-ribose101. Unexpectedly an enzyme generating cyclic ADP-ribose has been
identified as CD38 surface antigen of human lymphocytes from comparison of the
amino-acid sequence of an ADP-ribosyl cyclase from Aplysia102. Enzymatic activity
of the surface antigen has since been confirmed103. A role for cyclic ADP-ribose as
a second messenger for calcium mobilisation in the endoplasmic reticulum has been
demonstrated in pancreatic B cells104 and synthesis of cyclic ADP-ribose is enhanced
by cGMP105. In cardiac muscle the mechanism of action of cyclic ADP-ribose is to
activate directly the non-skeletal type ryanodine receptor Ca2+ channel, by increasing
the frequency of the opening of the channel106. How this is achieved has not been
shown; it may be that cyclic ADP-ribose covalently modifies the ion channel and such
a process may account for some of the non-enzymatic ADP-ribosyltransfer reactions




The effects of nitric oxide, a short-lived highly reactive gas, on cellular
regulation are widespread and diverse, e.g. tumoricidal and bactericidal properties of
white blood cells, smooth muscle relaxation and neurotransmitter107. This small
molecular effector is generated in cells by the action of nitric oxide synthetase from
arginine. The reaction requires NADPH and molecular oxygen, and is under the
control of Ca2+/calmodulin. Nitric oxide can diffuse freely across membranes and its
effects are mediated through guanylyl cyclase. Nitric oxide binds to the haem part
of soluble guanylyl cyclase, stimulating the formation of cyclic GMP, which in turn
stimulates protein kinase and increased phosphorylation of target proteins. Several
groups have noted changes in the levels of ADP-ribosylation of specific proteins in
response to nitric oxide suggesting an alternative cGMP independent cascade system.
1.5 4.1 Rod outer Segment Membranes
Several membrane proteins are labelled by endogenous ADP-ribosylation in
rod outer segments of the eye, 116 kDa, 66 kDa, 46 kDa and transducin,108. ADP-
ribosylation of the 116 kDA, 66 kDa and 46 kDa proteins were inhibited by exposure
of the membranes to nitric oxide, whereas transducin was stimulated. Whether the
effects observed were due to modification of the substrates or of the ADP-
ribosytransferases concerned was not addressed.
1.5.4.2 Platelets
Briine and Lapetina109 observed a novel endogenous ADP-ribosyltransferase
activity in human platelets. The activity was stimulated by nitric oxide and lead to
ADP-ribosylation of a 39 kDa cytosolic protein. Several unique characteristics of this
transferase reaction were noted110. (1), It was stimulated by nitric oxide. (2), Thiol
reagents were required for activity to be observed. (3), The reaction was inhibited
by treatment with N-ethyl maleimide (NEM). (4), The reaction was stimulated by
phosphate ion and inhibited by sodium chloride. (5), The modified protein was stable
to hydroxylamine and mercuric chloride. (6), ADP-ribosylation was independent of
guanylyl cyclase. (7), NADPH, but not NADP+ could stimulate the reaction.
Characterisation of the substrate protein was important to understand the
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relevance of this modification. Sufficient protein was recovered from a gel to perform
N-terminal sequence analysis. Comparison with known sequences identified the
protein as glyceraldehyde-3-phosphate dehydrogenase (GAPDH)111. It was then
discovered that the reaction was non-enzymatic. GAPDH was auto-ADP-ribosylated
and inactivated in the presence of [32P]NAD+ and nitric oxide releasing reagents
only112. Analysis of the chemistry of the reaction by Mc Donald and Moss"3 showed
that whole NAD+, and not ADP-ribose was covalently bound to GAPDH. A
mechanism for this was proposed in which cysteine groups react with nitric oxide.
The reactive intermediate, S-nitrosylated cysteine is then able to react directly with
NAD+ and covalently modify the enzyme. The ability of other dehydrogenase
enzymes to be modified was investigated. Labelling and inactivation of alcohol
dehydrogenase, lactate dehydrogenase114 and aldehyde dehydrogenase115 have since
been reported although different mechanisms are involved as they were not stimulated
by nitric oxide. Although NAD+ dependent modification of GAPDH is not a true
ADP-ribosyltransferase reaction it may be important physiologically and may explain
some of the toxic effects of nitric oxide.
1.5.5 Growth and Differentiation
1.5.5.1 GTP-binding Proteins
In neuronal tissue, growth is regulated by a family of growth associated
phosphoproteins (GAP). GAP-43 is the best characterised of these proteins. Its
expression has been closely correlated with axonal growth and it is found on the inner
surface of the plasmamembrane, especially at the growth cone, where it interacts with
G proteins. Although its normal action in vivo is unclear, GAP-43 has been shown
to bind calmodulin, be posphorylated by protein kinase C and to inhibit
phosphatidylinositol phosphate kinase. Most recently it has been shown to be ADP-
ribosylated implicating a role for ADP-ribosylation in growth and regeneration in the
nervous system116.
1.5.5.2 Nutritional Stress
The family of 70 kDa heat shock proteins and glucose-regulated proteins are
synthesised and accumulated in the cell when the cell is challenged eg starved of a
vital nutrient. These proteins are involved in the assembly of secretory and integral
membrane proteins. The major mono-ADP-ribose acceptor protein in vivo in avian
and murine cells was identified as 83 kDa stress induced and glucose-regulated
protein117. Reversible ADP-ribosylation of the 78 kDa glucose-regulated protein in
mouse hepatoma cells in response to starvation of the cells with either glucose or
tryptophan has been reported by Leno and Ledford118 thus implicating ADP-
ribosylation with a novel cellular metabolic control mechanism.
1.6. Aims of Project
The level of understanding of the nature of these endogenous ADP-
ribosyltransferases is poor relative to the extent of knowledge concerning the bacterial
toxins. Evidence supported by indirect studies show that endogenous ADP-
ribosylation is an important covalent modification of proteins by which their activities
are modified. Endogenous ADP-ribosyltransferase activity has been linked with a
variety of cellular processes eg receptor mediated signal transduction, calcium
signalling and growth and differentiation. Some of the activities appear to mirror the
action of bacterial toxins while others appear to be unique to certain cell types. The
ADP-ribosylation modification is quite specific compared to phosphorylation; only a
few modified protiens are commonly observed ranging in molecular weight from
21 kDa to 120 kDa. Most of these proteins are membrane bound and another
common feature is their ability to bind nucleotides. Relatively few endogenous ADP-
ribosyltransferases have been purified and most of these have been arginine specific.
In vivo estimates of the amount of ADP-ribosylated protein suggest that proteins
modified through cysteine residues are equally abundant. However only one NAD+:
cysteine ADP-ribosyltransferase has been purified. A classical protein biochemical
approach to purify a NAD+: cysteine ADP-ribosyltransferase activity was taken in
favour of a molecular biological one because of the lack of amino acid identity
between the known ADP-ribosyltransferases on which to base oligonucleotide probes.
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The aims of the project were:
(1) To purify an endogenous cysteine specific ADP-ribosyltransferase from bovine
blood.
(2) To investigate the kinetic properties of this purified enzyme and compare them to
the known endogenous ADP-ribosyltransferases and the bacterial protein toxins.
(3) To demonstrate ADP-ribosylation of a target membrane protein in re-sealed inside
out erythrocyte membranes and see if it is the same as pertussis toxin.
(4) To raise antibodies against the purified ADP-ribosyltransferase such that the
distribution of the enzyme could be investigated.
(5) To determine the N-terminal amino acid sequence of the purified protein to






Purified pertussis toxin was a kind gift from Dr L. Irons (the public health
laboratories, Porton down, Salisbury, U.K.) and also Dr K. Capiau (Smithkline
Beecham, Rixensart, Belgium). Radiochemicals, [3H-nicotinamidelNAD+, [carbonyl-
14C]NAD+ and [32P-adenylate]NAD+ were purchased from Amersham and [3H-
adenine]NAD+ was purchased from New England Nuclear. Antibodies against the
C-terminal portion of G,a and Gsa were a kind gift from Dr G. Milligan
(department of Biochemistry, Glasgow University). Horseradish peroxidase anti-
mouse IgG and anti-rabbit IgG conjugates were supplied by the Scottish antibody
production unit (SAPU). All other chemicals used were of the highest grade possible.
2.2 Activation of Pertussis Toxin
Activation of the whole toxin is requires before NAD+-glcohydrolase activity
or ADP-ribosyltransferase activity can be detected. Activation of the toxin is achieved
by promoting the release of SI subunit from the B oligomer and the reduction of an
intramolecular disulphide bond of the SI subunit. The optimised conditions described
by Kaslow et al.22 were followed. Pertussis toxin was stored as a saturated
ammonium sulphate suspension (2 mg/mL), at 4°C. The pertussis toxin precipitate
was removed by centrifiigation (13000g, 10 min) and then resuspended in 50 mM
potassium phosphate, 100 mM NaCl, pH 7.0. Excess ammonium sulphate was
removed by dialysis. The toxin was incubated with 10 mM dithiothreitol, 0.1 mM
ATP and 1% CHAPS at 37°C for 15 min before assaying for activity.
2.3 NAD-Glycohydrolase Assay
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This may be considered to be the enzymatic half reaction of ADP-
ribosyltransfer. The enzyme catalyses the hydrolysis of the glycosidic linkage
between ADP-ribose and nicotinamide of NAD+. Water or free aminoacid acts as a
nucleophilic acceptor for the ADP-ribose moiety. Moss and Vaughan119 developed an
assay to follow this reaction by measuring the concomittant release of nicotinamide.
Simply, 3H nicotinamide product was separated from [3H nicotinamide]NAD+ using
a small miniprep ion exchange column.
2.3.1 Incubation
A typical assay contained 50 mM phosphate buffer pH 7.0 and 100 /xM
(3H nicotinamide^AD+ (1 mCi/mmole). Control incubations, without any enzyme
added, were run for each reaction condition to account for background non-enzymic
hydrolysis of NAD+. Reactants were added to give a final reaction volume of 150 /zL
and incubated in a water bath at 30°C.
2.3.2 Detection Nicotinamide Released
The reaction was stopped by addition 0.85 mL ice cold water and then 0.9 mL
aliquot removed and applied to 0.5 mL washed Dowex AGIX anion exchange resin
(Sigma). Unbound [3H]nicotinamide was washed off the column with two volumes
of water 0.5 mL each. An aliquot of 0.5mL was removed from 2 mL of eluate and
4 mL of scintillation cocktail (HiSafe, Pharmacia/ Ultima Gold, Packard) was added.
Radioactivity was detected by scintillation counting for 2-10 minutes using a Packard
1900CA scintillation counter. Duplicate assays were measured for each time point
and reaction conditions set such that a maximum of 20% NAD+ was turned over.
Pertussis toxin catalysed NAD'ase activity (pmol'min1) was calculated using:
1Average counts releasedtPP - Background! x dilution factor Ccpml
Specific Activity NAD+(cpm/pmol) x Time (min)
Similarly, the cysteine dependent activity of the endogenous enzyme was
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calculated. Instead of total counts detected the difference between incubations with
and without cysteine for enzyme and blank was determined.
lENZYME(cpm(+cys) - cpmt-cvsfi - BLANKtcpmt+cvsl - cpm(-cysl)] (cpm)
Specific Activity NAD+(cpm/pmol) x Time (min)
2.3.3 Curve Fitting
The rates of nicotinamide release, calculated under various assay conditions,
were used to determine kinetic parameters for pertussis toxin and the purified cysteine
dependent NAD glycohydrolase (see chapter four). A non-linear regression curve
fitting package was used to fit the data to proposed kinetic models. The package used
was Regression (Blackwell Scientific Publications Ltd) and was operated under a
Windows environment. Non-linear regression was used in preference to linear
transformations of the data which can distort experimental results. The parameters
for a line are optimised iteratively and by minimising the sum of the squares, thus
giving the "goodness of fit" of a data set for a particular model. It does not find a
best fitting line through a data set. Simple weighting was used unless otherwise
stated.
2.4 The Separation of NAD+and ADP-ribose by HPLC.
2.4.1 Reverse Phase HPLC
The products of the NAD-glycohydrolase assay were separated out on an ODS-
HYP 2734 (HIGHCHROM) reverse-phase column (250 mm x 4.6 mm) using ALTEX
equipment, following the methodology developed by Lobban and van Heyningen120.
The relative retention times of the charged nucleotides on the reverse-phase support
are maximised by the use of a quarternary ammonium "solvophobic ion".
The column was stored in 20 % isopropanol, and was cleaned by washing with
one column volume 100 % isopropanol (HPLC grade, BDH) and then rinsed with
filtered, de-gassed, double distilled water ( five column volumes, 0.1 mL/ min,
maximum pressure 3000 p.s.i.). The column was equilibrated with 95% 10 mM
ammonium phosphate buffer pH 3.5, 5% methanol (filtered and de-gassed). The
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optimum running conditions, for separation of the products was 1 mL/min, 1000
p.s.i.
2.4.2 Ion Exchange HPLC
With time the reverse phase column deteriorated. This may have been
compounded by the use of ammonium salts which are known to shorten column life
by irreversible changes of the stationary phase characteristics. Slow flow rates had
to be employed to avoid high pressures, which effected the retention time of ADP-
ribose such that resolution of potential ADP-ribose-cysteine and ADP-ribose could not
be achieved. An alternative separation method was employed which separated the
products of the NAD-glycohydrolase assay on the basis of charge using a Sherisorb-
SAX ion exchange column (50 x 4.6 mm) (Anachem). The method of West9 was
followed. The column was stored in 25 % methanol and was prepared for use by
consecutive washing with one column volume of double distilled water, one column
volume of 1 M NaCl and one column volume of double distilled water. The column
was equilibrated with ten column volumes of 100 mM mono-basic potassium
phosphate pH 4.5. Separation of the products of NAD-glycohydrolase reaction was
achieved by isocratic elution at a flow rate 1 mL/min, 1000 psi. All reagents were
filtered and de-gassed before applying to the column.
2.4.3 Sample Treatment
After the NAD-glycohydrolase incubation was complete protein was removed
from the assay mix by filtration through a membrane with a cut off of Mr 10,000
(Millipore, micro-concentrator). The filtrate was stored on ice and then 100 /iL
aliquot was removed and analyzed by HPLC. The products of the NAD
glycohydrolase assay were eluted isocratically and detected by a U.V. monitor at 254
nm. Fractions were collected at 15 second time intervals using an LKB fraction
collector. 4 mL of scintillation fluid (HiSafe, Pharmacia/ Ultima Gold, Packard) was
added and counted in Packard 1900 CA scintillation counter for 10 minutes to detect





The concentration of soluble protein was estimated using the Bradford
reagent121. A five times concentrated stock solution was diluted to a one times
working solution as required. 100 /zL of protein sample was mixed with 900 /xL
diluted Bradford reagent and a blue colour was allowed to develop for a minimum of
15 min at room temperature. The absorbance at 595 nm was measured using a Thecil
spectrophotometer. The protein concentration was estimated from a standard curve
generated using a 1 mg/mL bovine serum albumin stock solution. The reaction was
linear over the range of 1 - 25 /zg protein per mL of reagent.
The concentration of membrane proteins was estimated using Peterson's122
simplification of the method of Lowry123. 5-60 /zg of protein was precipitated at room
temperature on addition of 0.15% (w/v) sodium deoxycholate and 10% (w/v) TCA.
The precipitate was collected by centrifugation (10,000 g, 5 min). The pellet was
solubilised in copper tartrate carbonate solution containing 2.5% SDS. The protein
was then mixed with Folin-Ciocalteau phenol reagent and the absorbance at 750 nm
was measured using a spectrophotometer (Thecil) after 30 min. BSA was used as a
standard for this reaction.
2.5.2 SDS Polyaerylamide gel electrophoresis
Proteins were separated under denaturing conditions using discontinuous buffer
system124. Tall Mighty Small mini-gel apparatus was used (Hoefer Scientific
Instruments ). There are several advantages of this system, compared to the large slab
gel apparatus. Less reagents are required (smaller quantities of aerylamide - a
neurotoxin - have to be handled). The process is quicker due to faster separation
times (90 min compared to overnight) and faster staining procedures (15 min
compared to several hours with Coomassie Blue ). Also, less sample is required, as
little as 1 /zg protein/band is detectible by Coomassie staining, using this system.
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2.5.2.1 Preparation of gels
The resolving gel mix contained 0.375 M Tris-HCl, pH8.8, 0.1% Sodium
dodecyl sulphate (SDS) and a stock solution of 30% (w/v) acrylamide, 0.8% (w/v)
bis-acrylamide was added to give the required percentage of acrylamide for resolution
of proteins. Pertussis toxin sub-units were routinely separated on 171/2% acrylamide
gels. The purification of cysteine dependent NAD'ase was monitored using 12% gels
and ADP-ribosylated membrane proteins were separated on 10% gels. Polymerisation
was initiated by the addition of freshly prepared 10% (w/v) ammonium per sulphate
(APS) and TEMED to give a final concentration of 0.1% (w/v) and 0.07% (v/v)
respectively. A 4% (w/v) acrylamide stacking gel was applied to the top of the
resolving gel containing, 0.125 M Tris-HCl, pH 6.7, 0.1% (w/v) SDS, 0.05% (w/v)
APS and 0.05% (v/v) TEMED.
2.5.2.2 Sample Treatment
A four times concentrated sample buffer was prepared containing, 0.25 M
Tris-HCl pH6.8, 8% SDS, 40% glycerol, 20% (v/v) 2-mercaptoethanol and 0.1%
(w/v) bromophenol blue. Soluble samples were dialysed against low ionic strength
buffer to remove salt and sample buffer was added one part to three. The protein
samples were then placed in a boiling water bath for 2 min, cooled and then spun
13000 g to remove any aggregates. 0 - 20 /ig of protein in 30 /iL was loaded per
lane. Insoluble precipitated protein samples were solubilised in 8 M urea (freshly
prepared) first, and then sample buffer was added as described above. Heating was
not necessary to solubilise proteins treated in this way. Membrane proteins were
solubilised in 50 mM Tris-HCl, pH 6.8, 2% SDS by heating 85 C for 20 min and
then treated as described for the soluble sample.
2.5.2.3 Coomassie Staining
0.25 g Coomassie Brilliant Blue R was dissolved in 1 L 40% Methanol, 7%
acetic acid. This solution fixes and stains the proteins in the gel. Gels were stained
for 15 - 60 min and destained 60 - 180 min with 5% methanol, 7% acetic acid.
Sponges were added to the destain solution to bind the excess coomassie dye. As
little as 1 fig protein/band is detectible by this staining procedure.
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2.5.2.4 Silver Staining
A modification of the staining procedure described by Wraight125 was followed.
Gels were fixed for 15 min in methanol: acetic acid: water (20:10:7 (v/v)). The gels
were washed three times in 50 % methanol for a minimum of 1 h each. Between
washes the gel was re-hydrated with distilled water. 0.4 g silver nitrate was disolved
in 2 mL distilled water and added dropwise to 21 mL 0.1 M sodium hydroxide, 1M
ammonia solution and then diluted to 100 mL. The gel was stained for 15 min. The
gel was washed with distilled water three times (2 min each) and then developed using
0.005% (w/v) citric acid, 0.005% (v/v) formaldehyde developer. The reaction was
stopped by addition methanol: acetic acid: stop solution. Siver stain and developer
were prepared fresh on the day of use. Some gels were stained by both procedures.
Staining by one method does not affect the other.
2.5.3 Western Blotting
Specific proteins separated out on SDS polyacrylamide gels could be identified
with an antibody probe using the Western blotting technique. First, the proteins are
transfered from the gel onto a nitro-cellulose membrane. This is achieved by
constructing a "gel sandwich" consisting of three layers of blotting paper (Whatmann
3 MM) soaked in blotting buffer (50 mM potassium phosphate, 20% methanol,
pH 7.4), the gel, the nitro-cellulose membrane and three more sheets of buffer soaked
blotting paper. The "gel sandwich" is clamped tightly together and immersed in
blotting buffer. A voltage is then applied across the "gel sandwich". The negatively
charged proteins move towards the positively charged terminal but are immobilised
onto the nitro-cellulose. Complete transfer of erythrocyte ghost proteins from a 10%
polyacrylamide gel was achieved using transfer conditions of 1 A, constant current for
2 h.
Excess protein binding sites on the nitro-cellulose are blocked for 1 h by
incubation with 1 % (w/v) dried milk solids (Marvel) in 0.1 % (v/v) TWEEN in Tris
buffered saline, 50 mM Tris HC1, 150 mM NaCl, pH 7.4 (TBST). The blot is then
probed with the antibody raised against the protein of interest, eg anti-Gja and anti-
Gsq: (see chapter five, section 5.2.2). These antibodies were diluted 1/2000 with
TBST and were incubated with the blot for 2 h at room temperature. The unbound
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and loosely associated antibody were removed by sequential washing of the blot, three
times, with TBS, and TBST for 5 min each. Horseradish peroxidase IgG conjugate
was diluted 1/4000 to probe the blot for 1 h. The IgG component recognises the first
antibody and the catalytic activity of horseradish peroxidase is used to detect the
complex by the formation of a luminescent compound. Unbound and loosely
associated second antibody were removed by the sequential washing procedure
described above. ECL reagents (Amersham) are added to the washed blot and then
exposed to hyperfilm MP autoradiography film for 1-10 min. The ECL reagents are
used up after 2 h and the antibody can nolonger be detected. The autoradiography
film is developed using an automatic X-ray film developer.
2.5.4 Electro-elution of Protein from Polyacrlamide Gels
Strips of polyacrylamide gel containing protein were removed from the gel and
cut into 10 mm by 2 mm portions. These were positioned above the concentrating
cup on a piece of nylon membrane in the ISCO electroelution apparatus. The buffer
used was 10 mM potassium phosphate pH 7.5, 0.1% SDS. The proteins were eluted
on application of a constant voltage of 100 V for 3 h. The negatively charged protein
moves out of the gel matrix towards the cathode. The progress of the protein is
halted by the presence of a dialysis membrane of relative molecular weight cut-off of
5000, which seals the bottom of the concentrating cup. The eluted protein is
concentrated in the concentrating cup in a total volume of 50 /xL.
Chapter three
purification of an endogenous mono-adp-
Ribosyltransferase from bovine erythrocytes
37
3.1 Introduction
Mono-ADP-ribosylation is a covalent modification of proteins in which a
single ADP-ribose is transferred from NAD+ to an acceptor protein with concomitant
release of nicotinamide and a proton. A classic example of such a reaction is
exhibited by bacterial protein toxins. Each toxin modifies a specific amino-acid for
a specific target protein, e.g. cholera toxin ADP-ribosylates arg-201 of Gsa126,
pertussis toxin modifies C-terminal cys-352 residue ofQa9 and diphtheria toxin labels
the modified amino acid residue diphthamide of elongation factor 23. Such
modifications have a critical role in the pathogenesis of disease, by blocking of signal
transduction pathways or switching off protein synthesis. However ADP-ribosylation
also occurs physiologically; these reactions are less well characterised. For a detailed
review see chapter one.
Endogenous ADP-ribosylation has been studied by direct and indirect
approaches. The direct approach identifies the mono-ADP-ribosyltransferases
involved and can be used to answer questions such as: What is their substrate
specificity? What is their distribution? What factors effect their activity?
Endogenous ADP-ribosyltransferase activity showing the same specificity as bacterial
protein toxins has been identified in a variety of cell types. The enzymes responsible
have rarely been purified. The notable exceptions are the NAD+: arginine-ADP-
ribosyltransferases from turkey erythrocytes59 and rabbit skeletal muscle71 and NAD+:
cysteine ADP-ribosyltransferase from human erythrocytes76,77.
Indirect evidence comes from the study of the target proteins and the factors
which influence the level of ADP-ribosylation observed. These experiments hint
towards the physiological role of mono-ADP-ribosylation. Measurement of the level
of ADP-ribosylated protein in vivo shows that mono-ADP-ribosylation occurs mainly
outside the nucleus and accounts for 90 % of all ADP-ribosylated protein127. A role
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in signal transduction has been suggested, as levels of ADP-ribosylation are sensitive
to cAMP dependent128 and independent pathways108. Mono-ADP-ribosylation of target
proteins has been shown to cause Ca2+ flux93, phosphate transport129 and loss of target
enzyme activity74,114.
The aim of this project was to take a direct approach, to purify and
characterise an endogenous ADP-ribosyltransferase from bovine erythrocytes, which
had a similar substrate specificity to pertussis toxin. Bovine erythrocytes were chosen
as a source for the enzyme because large volumes were regularly obtainable from the
slaughter house and were relatively safe to handle. To purify the enzyme it was
assumed that, like pertussis toxin, it would catalyse the transfer of ADP-ribose to G,a
and also have a cysteine dependent NAD+ glycohydrolase (NAD'ase) activity. The
NAD'ase reaction describes the hydrolysis ofNAD+ to ADP-ribose, nicotinamide and
H+ and can be measured by detecting the amount of [3H]-nicotinamide released from
[3H-nicotinamide]NAD+ by separation of the product on an ion exchange resin. The
role of cysteine in the assay would be to act as an acceptor for ADP-ribose or to
activate the enzyme resulting in an increase of the rate of nicotinamide released.
Cysteine dependent activity is measured as the difference between duplicate assays
with and without cysteine. This assay was adopted to monitor the progress of the
purification procedure because it allows a large number of samples to be screened at
one time; it is quantitative; it is quick and relatively cheap. The ADP-ribosyltransfer
assay is impractical because only a limited number of samples can be assayed at one
time; it is difficult to quantitate; it is time consuming and expensive.
In this chapter the development of a three step purification to purify a cysteine
dependent NAD'ase is described. Three major problems had to be addressed. (1)
The major contaminant from which it is purified is one protein, haemoglobin, which
probably accounts for more than 95 % of the total soluble protein in the bovine
erythrocyte. (2) A variety of NAD'ase and ADP-ribosyltransferase activities are
present in the crude fractions from which the cysteine dependent activity has to be
resolved. (3) The cysteine dependent activity was extremely labile.
3.2 Preparation of Bovine Erythrocyte Lysate
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3.2.1 Method
1 L bovine blood was collected (J. Stoddart Ltd, Slateford slaughter house,
Edinburgh) and 0.1 L 3.8 % (w/v) sodium citrate was added as an anti-coagulant.
The erythrocytes were centrifuged (5000g, 10 min) and washed three times with
phosphate-buffered saline, 12.7 mM potassium phosphate, 133 mM NaCl, 3 mM KC1,
1 mM MgCl2, pH 7.4 (PBS). The supernatant and the top layer of cells were
discarded for each wash to ensure efficient removal of platelets. The cells were lysed
with 10 mM sodium phosphate, 0.1 mM phenylmethylsulphonyl fluoride (PMSF),
0.1% 2-mercaptoethanol, pH 7.8 hypotonic buffer. Unbroken cells and ghost
membranes were removed by centrifugation (14000g, 30 min).
3.2.2 Results
It was estimated that 1 L of blood produced 60-80g protein using Bradford
reagent with BSA as a standard (as described section 2.5.1). This was a lower
estimate than expected, as normal cows have 115 g/L haemoglobin in their blood.
If the Bradford reagent does not react with haemoglobin to the same extent as with
BSA, it could cause significant lowering of the protein estimation, since haemagloblin
was the major protein present in this fraction. Alternatively, this low protein yield
may be explained by the washing procedure used to prepare the bovine erythrocytes.
The erythrocytes were washed three times with PBS. After each wash the top layer
of cells was discarded to ensure efficient removal of platelets, which appear as a shiny
layer of cells between the loose erythrocyte pellet and the buffy coat. The lysate
contained a high level of non specific NAD'ase activity. Figure 3.1 shows the dose
response curve obtained for fresh lysate in the presence and absence of 100 mM
cysteine. A small increase in the rate of nicotinamide released was observed in the
presence of cysteine and this difference was measured as the cysteine dependent
NAD'ase. The rate of nicotinamide release in response to addition of greater than 2.5
mg lysate proteins in the presence of 100 mM cysteine became non-linear. This was
probably due to substrate depletion and/or product inhibition, since 30% of the total
NAD+ (15 nmole) is hydrolysed during the time course of the assay (30 min) on
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Lysate protein added per assay (mg)
Figure 3.1 Dose Response Curve for Bovine Erythrocyte Lysate
Duplicate assays, with [#] and without [O] 100 mM cysteine were set up and the
NAD'ase assay was performed as described in section 2.3.
addition of 2.5 mg lysate proteins. The rate of cysteine independent NAD'ase activity
was linear over the range of lysate protein added (0-7.5 mg). A cysteine dependent
increase in the rate of nicotinamide release was only observed in freshly prepared
lysate and was not detectible after storage at 4°C overnight. To detect the cysteine
dependent activity reliably, it must constitute more than 15% of the total NAD'ase
activity in the presence of cysteine, in order that any significant difference between
assays with and without cysteine can be measured. From the linear portion of the
dose response curve the specific activities of the lysate protein were calulated. Total
NAD'ase activity in the absence of cysteine is 60 pmol/min/mg. The addition of 100
mM cysteine increases NAD'ase activity observed 100%, to 120 pmol/min/mg.
Calculating the difference between these activities gives a cysteine dependent activity
of 60 pmol/min/mg.
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3.3 Ammonium Sulphate precipitation
Ammonium sulphate precipitation provides a crude fractionation step which can
easily be applied to large sample volumes (1 L). Different proteins have different
charges and will be selectively salted out at different concentrations of ammonium
sulphate. As a result very dilute components of the protein mixture may be
concentrated and clearly separated from the bulk of the contaminating protein.
3.3.1 Method
A subtractive ammonium sulphate cut was performed on the crude lysate at
o
4 C. Solid ammonium sulphate (BDH, especially low in heavy metals) was added
to give a 35% saturated ammonium sulphate solution (at 20 °C). The precipitate was
removed by centrifugation (14,000 g, 30 min) and the supernatant was increased to
40% saturated ammonium sulphate solution. This procedure was repeated from 35%
to 80% of saturation in 5% intervals. The protein precipitated in each fraction was
solubilised in 50 mM phosphate buffer, pH 7.0, 30% ethylene glycol, 0.1 mM
PMSF, 0.1 mM EDTA and 1.0 mM benzamidine (buffer A). Each fraction was
assayed for cysteine dependent NAD'ase activity (section 2.3) and for the amount of
protein present (section 2.5.2).
3.3.2 Results
Table 3.1 shows the data obtained using this subtractive cut procedure.
NAD'ase activity was precipitated at low ammonium sulphate saturation and was
clearly separated from the bulk of the protein. Cysteine dependent activity was
concentrated in the 35 - 45% saturation fractions. 25 fold purification was ahieved,
as the bulk of the haemoglobin was removed. Gels (not shown) of the proteins
precipitated between 30 and 60 % saturated ammonium sulphate showed several bands
in the region of 20 - 80 kDa and some haemoglobin. At 60% of saturation and above
only haemoglobin was evident.
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30 2400 - -
30-40 1800 3000 1660
40-45 2700 1200 440
45-50 11600 - -
50-60 27500 - -
60-70 30500 - -
70-80 - - -
Following this experiment, precipitation with 40% Ammonium sulphate
saturation was adopted as the first step of the purification. 80% of the protien was
removed by this step, but was still contaminated by non-specific NAD'ase activity the
dose response curve in the presence and absence of cysteine is shown in Figure 3.2.
Activity yields of 70 - 90% were routinely achieved from fresh material. The
stability of the cysteine dependent activity, stored as an ammonium sulphate
precipitate under various conditions was tested. Figure 3.3 shows that the activity
o o
was extremely labile at 4 C but was stable on freezing at -16 C. No loss in activity
was seen over three months.
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40 % Ammonium sulphate precipitated protein (ug)
Figure 3.2 Dose Response Curve for 40% Saturated Ammonium Sulphate
Fraction. Duplicate assays, with [•] and without [o] 100 mM cysteine were
performed as described in section 2.3.
Time (days)
Figure 3.3 The stability of the 40 % ammonium sulphate fraction on storage
at 4°C (O) and -16 °C (•). The specific activity at time zero was 1600
pmol/min/mg.
3.4 Cysteine sepharose affinity column
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The aim of this purification procedure is to purify an ADP-ribosyltransferase
which can modify a cysteine residue on a target protein. In this next step this
property is exploited. The cysteine-sepharose may mimic the ADP-ribosyltransfer site
of the target protein, thus allowing the enzyme to bind to the column. Non-specific
NAD'ase activity and ADP-ribosyltransferases specific for arginine residues should
not bind. Disulphide exchange may occur between protein disulphide bridges and
the free cysteine exposed on the sepharose support. This interaction will be inhibited
by the presence of free thiol groups in the buffers used.
3.4.1 Method
3.4.1.1 Preparation of Column
A cysteine Sepharose column was prepared by the reaction of free cysteine
with cynanogen bromide-activated Sepharose 4B (Pharmacia), following the
manufacturer's recommended protocol. Cynanogen bromide-activated Sepharose was
swollen in 1 mM HC1 and washed on a scintered glass filter with 1 mM HC1
(200 mL/ lg gel). The gel was washed with 0.1 M sodium carbonate pH 8.3, 0.5 M
NaCl (coupling buffer) and then reacted with 2 mM cysteine in coupling buffer for
2 h at room temperature with gentle mixing. The recommended ligand concentration
is 1 - 10 /zmole ligand/ mL gel. Excess activated groups were blocked with 0.2 M
glycine in coupling buffer for 16 h at 4°C with gentle shaking. The gel was washed
with coupling buffer followed by 0.1 M acetate pH 4.0, 0.5 M NaCl for five cycles
to remove blocking reagent.
20 mL of gel was poured into Pharmacia XL column (2.5 cm x 10 cm) and
packed at 1 mL/min. The column was equilibrated with 50 mM potassium phosphate
buffer pH7.0, 30% ethylene glycol. After use, the column was regenerated by
successive washing with one column volume 1 M NaCl, one column volume water,
one column volume 10 mM phosphate pH 7.0, 0.1 % 2-mercaptoethanol. Finally the
gel was stored in 0.1 M acetate pH 4.0 at 4°C.
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3.4.1.2 Measurement of Free Thiol
The availability of free thiol was tested using Ellman's reagent - 5,5'-
dithiobis(2)nitrobenzoic acid) (DTNB). Disulphide exchange between DTNB and free
thiol groups present in solution occurs, which results in the release of 5-thio-2-
nitrobenzoic acid which is yellow coloured (e412 = 13600 M 'cm1). The method
described by Habeeb was followed130. A stock solution containing 40 mg DTNB,
dissolved in 30 mL 0.1 M sodium phosphate pH 7.2, was prepared. 0.1 mL of this
reagent was added to 0.9 mL sample and the colour allowed to develop for 15 min,
at room temperature. The absorbance at 412 nm was measured using a Cecil
spectrophotometer. Micromolar concentrations of free thiol can be detected using this
reagent.
3.4.1.3 Sample Treatment
The 40% ammonium sulphate pellet was solubilised and dialysed against
buffer A to give a final protein concentration of 2-10 mg/mL. The material was
applied slowly to the cysteine-Sepharose column (0.2 mL/min) to allow the protein
to bind. The column was washed with ten column volumes of buffer A. Bound
protein was eluted by successive washing with buffer A containing 0.1% 2-
mercaptoethanol (buffer B), buffer B containing 0.1 M NaCl and buffer B containing
0.5 M NaCl.
3.4.2 Results
The cysteine sepharose affinity column was prepared following the
manufacturer's protocol. The free thiol group is a reactive nucleophile and may react
in preference to the amino group with the cyanogen bromide. Ellmans reagent was
used to confirm the amount of free thiol bound to the column. 2.5 /xmoles/ mL gel
were detected. This is within the recommended concentration of affinity reagent 1 -
10 /xmoles/ mL gel.
Protein binding to cysteine Sepharose is allowed to occur at pH 7.2. At this
pH the carboxyl groups of cysteine and glycine (used to block the unreacted cyanogen
bromide sites) will be negatively charged. To test whether the cysteine Sepharose







Figure 3.4 Percentage Protein and Activity Recovered from Cysteine
Sepharose and Glycine Sepharose. 10 mg protein containing 10 nmol/min activity
was loaded onto each column.
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of the cysteine dependent activity for cysteine Sepharose and glycine Sepharose were
compared. Trial columns were set up (2 mL each) and 10 mg protein, containing 10
nmol/min cysteine dependent NAD'ase activity was loaded. Figure 3.4 compares the
percentage protein and activity recovered from the cysteine Sepharose column and the
glycine blocked Sepharose column. The protein profdes are similar. 85 % of the total
protein did not bind to the column, 15% of the total protein bound to the column and
was eluted with buffer B containing 0.5 M NaCl. Cysteine dependent activity,
however bound to the cysteine sepharose column only and was eluted with buffer B
containing 10 mM cysteine and 100 mM sodium chloride. Importantly haemoglobin
and non-specific NAD'ase activity did not bind to either matrix.
Optimum binding of cysteine dependent NAD'ase to the cysteine sepharose
column was achieved at protein concentrations 2-10 mg/mL and after allowing slow
binding reactions to occur over one hour at zero flow rate. Low concentrations of
protein lost activity rapidly and high concentrations of protein inhibited binding of
cysteine dependent activity to the column, possibly by causing protein elution. Very
dilute protein concentrations (less than 0.05 mg/mL) were obtained after this step,
and the activity was extremely labile at 4°C. 50% of the cysteine dependent activity
was lost in 3.5 h at 4°C in the presence of reducing reagent and is shown in
Figure 3.5. Activity yields were variable; 10-40% for large scale preparations and
50-70% for small scale preparations. These observations can be primarily attributed
to the labilility of the activity with time. Large prepartions take longer to apply to
the column compared to small scale ones (10 h compared to 1 h). Some stabilisation
of the enzyme was achieved by the introduction of ethylene glycol and protease
inhibitors. Early experiments carried out in the absence of ethylene glycol lead to no
recovery of activity. In the absence of protease inhibitors, low molecular weight
bands running with the dye front were observed on SDS polyacrylamide gels,
suggesting that the sample was susceptible to proteolysis, and this may be correlated
with a reduction in activity yield. SDS polyacrylamide electrophoresis of this semi-
purified fraction shows that three protein bands, 90 kDa, 45 kDa and 28 kDa are
visible by silver staining (see Figure 3.8).
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Figure 3.5 Time Dependent Inactivation of Semi-purified Fraction from
Cysteine Sepharose.
The sample was stored in 50 mM potassium phosphate buffer, 10 mM cysteine, 100
mM NaCl, pH 7.2 at 4°C
The cysteine dependent NAD'ase has been purified 20,000 fold with a specific
activity 28.5 nmol/min/mg. It has been successfully separated from the non-specific
NAD'ase activities which do not bind to the column and the major contaminating
protein, haemoglobin, has been completely removed.
3.5 NAD+ Binding Affinity Chromatography
Dye ligands have often been used to mimic NAD(H) binding and have
successfully used to purify NAD(H) utilising enzymes. The affinity of the cysteine
dependent NAD'ase for a variety of dyes was tested using the dyematrex (Amicon)
ligand trial binding kit. The kit contains, 1 mL each of blueA, blueB, green, orange
and red dyes covalently bound to Sepharose and also un-modified support as a control.
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3.5.1 Method
The sample was dialysed against buffer A containing 0.1 % 2-mercaptoethanol
to remove the salt. A 1 mL aliquot of known activity was applied to each column and
binding allowed for 1 h. The columns were washed with 10 column volumes of
buffer A to remove unbound material. Salt was added in a stepwise gradient, 0.1 M,
0.2 M, 0.5 M and 1M NaCl. Each fraction was tested for cysteine dependent
NAD'ase as descibed in section 2.3.
3.5.2 Results
Table 3.2 Dye Affinity Ligand Binding Trial
ligand % Activity Unbound % Activity Recovered
in Salt Washes
Blue A 50 30





The cysteine dependent NAD'ase had a high affinity for all of the dye ligands
tested, but the best recovery of activity was from Matrex orange. No activity was
bound to the unmodified sepharose column, which shows that the cysteine dependent
activity has an affinity for the dye ligands rather than non-specific binding to the
Sepharose support. An added advantage of Matrex orange compared to Matrex red
or blue B was noted when samples containing both cysteine dependent and
independent NAD'ase activities were loaded onto these trial columns (results not
shown). Cysteine dependent and independent NAD'ase activities had similar affinities
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Purified protein (ug)
Figure 3.6 Dose Response Curve of Cysteine Dependent NAD'ase after
purification on dye affinity column. Duplicate assays with (•) and without (O) 100
mM cysteine were performed.
for Matrex red and Matrex Blue, whereas the cysteine independent NAD'ase activity
did not bind as tightly as the cysteine dependent activity to Matrex orange. Matrex
orange gave the best recovery and best resolution of cysteine dependent activity of the
ligands tested, and therefore was chosen for the final purification step.
To achieve a high recovery of activity for this step the time required for
binding and elution from the column must be minimised because of the lability of the
dilute semi-purified material obtained from the cysteine Sepharose column
(Figure 3.5). This was achieved best by adding 2 mL Matrex orange gel with 30 mL
semi-purified sample and rotating the mixture gently for 1 h to allow binding to
occur. Then the gel was allowed to settle and the supernatant, containing unbound
protein was removed. The gel was then washed and the bound activity eluted as
described in section 3.5.1. Binding of the activity was improved by the presence of
0.01% 2-mercaptoethanol.
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Figure 3.7 Stability of Cysteine dependent NAD'ase on storage at -16 C in the
presence (O) or absence (•) of 0.01 %(v/v) 2-mercaptoethanol.
Cysteine dependent NAD'ase was eluted in buffer A containing 0.5 M NaCl,
and 60-80 % recovery of activity was routinely achieved. Very low concentrations
of protein were estimated by measuring the absorbance at 280 nm. 20-50 fig of
protein were recovered and silver stained SDS polyacrylamide gels show a single band
of 60 kDa. 70,000 fold purification has been achieved and the final product has a
specific activity of 700 nmol/min/mg (Figure 3.6). No NAD'ase activity was
observed in the absence of reducing reagent.
The sample was stored at -16 C in 50 mM potassium phosphate, 30 %
ethyleneglycol, 0.5 M NaCl, 0.1 mM PMSF pH 7.0 in the absence of thiol.
Figure 3.7 shows the loss of activity with time under these storage conditions. The
presence of thiol reagent rapidly inactivates the enzyme, whereas in its absence, the
enzyme can be stored for up to three months without loss of activity.
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3.6 Summary of Purification Procedure
Summarised here is the procedure developed to purify a cysteine dependent
NAD'ase activity from bovine erythrocytes. The typical protein recoveries and yields
of activity are shown in table 3.3. Each step was carried out at 4 C, unless
otherwise stated, and 30 % (v/v) ethylene glycol and 0.1 mM PMSF were added to
the buffers to help stabilise the enzyme activity.
Step one: Bovine erythrocytes lysate was prepared from 1 L of bovine blood,
and protein was precipitated with 40% saturated solution of ammonium sulphate. The
pellet was divided into six fractions and stored at -16 C. One aliquot was removed
at a time and processed through the remaining purification steps.
Step two: The precipitated protein was solubilised in buffer A and dialysed
to remove salts and traces of 2-mercaptoethanol. It was then applied to the cysteine-
Sepharose column (bed volume 30 mL) at a flow rate of 0.5 mL/min.
Step Three: The dilute semi-purified protein activity was mixed with Matrex
orange gel and allowed to bind. The bound activity was eluted with buffer A
containing 0.5 M NaCl and was stored directly in this high salt buffer at -16 C.
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Figure 3.8 12 % SDS-PAGE gel of Purification Steps. Lanes (a) lysate, (b)
ammonium sulphate, (c) cysteine sepharose and (d) matrex orange.
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3.7 Preparation of Antibodies
3.7.1 Introduction
The production of antibodies against the purified cysteine dependent NAD'ase
from bovine erythrocyte will provide a useful tool with which to study the distribution
of this enzyme in other tissues. Polyclonal antibodies, raised against pure antigen will
recognise a variety of epitopes. This should allow sensitive detection of cysteine
dependent NAD'ase in crude mixtures, where cysteine dependent activity is too low
to be detected. The antibodies were raised in mice because only a small quantity of
purified material was available following the three step procedure described. The
limited amount of hyperimmune sera produced would be enough to support the
intended studies. The antigen used was inactive purified cysteine dependent NAD'ase
which had suffered proteolysis to give 10-12 kDa fragments. Small, soluble,
monomeric proteins generally induce a poor immune response because they are poorly
phagocytosed. Therefore the initial immunisation was carried out in the presence of
Freunds complete adjuvant. This contains heat killed Mycobacterium tuberculosis,
which causes a non-specific stimulation of the immune response, and mineral oils
which prevent rapid catabolism of the antigen. The polyclonal antibodies raised were
then tested against antigen and active whole cysteine dependent NAD'ase on dot blots
and Westerns.
3.7.2 Method
3.7.2.1 Raising the Antibody
150 /xg cysteine dependent NAD'ase was concentrated to 1 mg/mL in 50 mM
phosphate, pH 7.0, 30% ethylene glycol, 0.5 M NaCl. 30 fiL aliquot was diluted
five fold with phosphate buffered saline and then mixed with an equal volume of
Freunds complete adjuvant. Pre-immune sera from three 8 week old BALB/C mice
were collected by tail bleed. Each mouse was injected subcutaneously in scruff and
flank with 5-10 fig antigen. An hyperimmune response was induced by injection of
5-10 fig antigen mixed with Freunds incomplete adjuvant into each mouse at 3 and 6
weeks. Test bleeds were taken at 6 weeks and the mice bled out at 8 weeks.
Approximately 1.5 mL of blood was collected from each mouse. The blood was
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allowed to clot for 30 min at 25 C. The clot was removed by centrifugation
(10,000g, 10 min) and the serum was stored at -16°C.
3.7.2.2 Antibody Detection
1 -5 fig of antigen were spotted onto nitrocellulose membrane and the excess
binding sites were blocked by binding of 5 % (w/v) dried milk solids in Tris buffered
saline (TBS) containing 0.1 % TWEEN (TBST). The pre-immmune and immune sera
were diluted 1:200, 1:500, 1:1000 and 1:2000 with TBST and incubated with the dot
blot for 2 hr. The dot blots were then treated as described in section 2.5.3 for
treatment of western blots with second antibody and detection by ECL.
3.7.2.3 Immuno-precipitation of Cysteine Dependent NAD'ase Activity
Active cysteine dependent NAD'ase was incubated with 1:500 dilute immune
and pre-immune mouse sera for 30 min, at 4 °C. Commercially available fixed
protein A presenting S. aureus cells, Pansorbin (Calbiochem) were added. 10 fiL
(10% w/v) were added to 200 /zL antigen, antibody mix and incubated for 30 min,
at 4°C. The cells were removed by centrifugation (10,000g, 4 min) and the
supernatants assayed for cysteine dependent activity.
3.7.3 Results
An hyper-immune response was induced in all of the mice. The antibodies
raised were able to recognise the antigen and active cysteine dependent NAD'ase
preparations on dot blots. No reaction was observed with the pre-immune sera.
Figure 3.9 shows the reaction of the pooled immune sera and pooled pre-immune sera
with native and denatured cysteine dependent NAD'ase as indicated. Unfortuneately
no reaction with Western blotted proteins was achieved under comparable protein
loading and antibody incubation conditions. SDS denatured antigen did not react with
the antibody on dot blots, suggesting that the reactive epitopes were sensitive to
denaturation.
Table 3.4 shows that 35% of the cysteine dependent NAD'ase activity
remained after incubation with immune sera and protein A. 95 % remained in the
presence of pre-immune sera and protein A. The activities observed were compared
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Antigen Pre-immune Immune Sera SDS treated
antigen
V-g 1/500 1/500 1/1000 1/2000 1/500
1 • 1 %
0.5 • |T; •
0.25 %
•
^igure 3.9 Recognition of antigen by pooled immune and pre-immune sera on
dot blots
to cysteine dependent NAD'ase treated similarly, but in the absence of sera or
protein A. This experiment confirmed that the antibodies raised against the degraded
cysteine dependent NAD'ase did recognise whole, active cysteine dependent NAD'ase.
Table 3.4 Immuno-precipitation of Cysteine dependent NAD'ase activity





Enzyme + pre-immune sera + protein A 95
Enzyme + immune sera + protein A 35
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3.8 Discussion
3.8.1 Bovine Erythrocyte Lysate as a Source for Cysteine Dependent NAD'ase
Examination of the lysate material illustrates two problems which have to be
overcome in order to purify the cysteine dependent NAD'ase. First, haemoglobin is
the single major contaminating protein. Coomassie staining of 10 fig lysate protein
separated on 12% SDS polyacrylamide gel (Figure 3.8) shows a single band at 16
kDa. If efficient removal of haemoglobin could be obtained then 30,000 fold
purification could be achieved in one step. However its presence in such excess, and
at high concentration may cause it to behave anomously. Second, the cysteine
dependent NAD'ase activity is not the only nicotinamide releasing enzyme present in
bovine erythrocytes.
The NAD glycohydrolase assay measures the total nicotinamide released in the
presence and absence of 100 mM cysteine, and the cysteine dependent activity is the
difference between the two activities measured. Accurate determination of the
cysteine dependent activity in crude fractions is difficult for three reasons. (1) The
assay measures the release of nicotinamide and not the production of ADP-ribose-
cysteine, directly. Several enzymes may be present in the lysate capable of catalysing
the hydrolysis of NAD+, for example, other ADP-ribosyltransferases such as the
NAD+: arginine ADP-ribosyltransferase59 and NAD glycohdrolases which are
particularly abundant in macrophage are also to be found in erythrocytes131. (2) The
cysteine dependent release of nicotinamide must account for at least 15% of total
nicotinamide released, in order that a significant difference between the [3H] counts
observed with and without cysteine in the assay may be detected. (3) It is possible
that some NAD glycohydrolases may be inhibited by cysteine. Inhibition and
activation of nicotinamide on addition of cysteine may cancel each other out such that
no cysteine dependent activity is observed.
The specific activity of the total NAD'ase activity observed in the absence of
cysteine is 60 pmol/min/mg protein. This is comparable to the activity quoted by
Artman and Seeley132 (40 pmol/min/mg) for NAD glycohydrolases in human
erythrocytes (determined by the cyanide procedure132). This suggests that the
erythrocyte preparation is free from platelet contamination, which have a ten fold
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higher NAD'ase activity (450 pmol/min/mg)132. The specific activity of the cysteine
dependent NAD'ase is 60 pmol/min/mg protein. This is four fold lower than that
quoted by Tanuma et al.75 (240 pmol/min/mg). This may reflect the different levels
of expression of this enzyme activity in bovine and human. However Tanuma et al.
used a different assay system. They claimed to have developed an assay system which
measured the levels of ADP-ribose-cysteine directly, by the selective binding of
product to DE52 ion exchange chromatography paper. Such an assay system was
tried (results not shown), but no selectivity could be obtained; ADP-ribose bound as
well as ADP-ribose-cysteine. If Tanuma's measurement is treated as total NAD'ase
activity in the presence of cysteine, then the specific activities observed in human and
bovine blood are similar. These data suggest that bovine erythrocytes are a suitable
source for the purification of a cysteine dependent NAD'ase.
3.8.2 Ammonium Sulphate Precipitation
Ammonium sulphate precipitation was used as a crude fractionation step to
concentrate the dilute cysteine dependent NAD'ase away from the main contaminating
protein, haemoglobin. This step proved very successful on two counts. First, 75 fold
purification was achieved, and 60-80% of the activity was recovered. Approximately
90% of the total haemoglobin and some of the non-specific NAD'ase activity were
removed by this step. Second, fortuneately the 40 % ammonium sulphate pellet could
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be stored at -16 C for several months without loss of activity. This allowed bulk
preparation of bovine erythrocyte lysate which could then be stored as manageable
aliquots in the form of the ammonium sulphate precipitate and defrosted as required
for further purification.
Previous protocols described by Moss et al.59 and Tanuma et al.15, for the
purification of endogenous ADP-ribosyltransferases do not involve ammonium
sulphate precipitation. The first step is binding to an hydrophobic support in batch.
60 % yields are quoted and similar fold purification (70 fold) achieved. A large
volume of support is required for application of 1 L lysate which requires long
process times for binding and elution of activity. This process results in very dilute
protein on elution of the bound activity from the hydrophobic support. The time
involved and the dilution factor made this step impracticable for the purification of
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the cysteine dependent activity observed in bovine erythrocytes, which is extremely
labile. The ammonium sulphate precipition provided a good alternative, by
concentrating the activity and stabilising it.
3.8.3 Cysteine Sepharose Affinity Chromatography
Tight binding of cysteine dependent NAD'ase onto the cysteine Sepharose
column, but no binding to the control support (glycine blocked Sepharose) was
observed. Elution was achieved by the addition of reducing reagent (0.1 % 2-
mercaptoethanol or 10 mM cysteine) and a high concentration of salt (0.5 M NaCl).
Reducing reagent on its own was not sufficient to displace the bound activity. These
data suggest that the strategy of using cysteine Sepharose to mimic the target protein
has worked. Simple thiol exchange may also play a role, however, as it was observed
that, binding of cysteine dependent NAD'ase to cysteine Sepharose was inhibited in
the presence of reducing reagent. In this step the cysteine dependent NAD'ase is
purified 6250 fold with a specific activity 250 nmol/min/mg. Three bands are visible
with silver staining 90 kDa, 45 kDa and 28 kDa (Figure 3.8). It has been
successfully separated from the major contaminating protein, haemoglobin and also,
clearly separated from the non specific NAD'ase activities. No NAD'ase activity was
observed for this semi-pure fraction in the absence of cysteine. Yields obtained for
this step are variable 10-60%. Loss of activity could sometimes be correlated with
evidence of proteolysis. Silver stained gels showed the appearance of a 24 kDa band
and a low molecular weight fragment running with the dye front (not shown). The
addition of protease inhibitors PMSF, EDTA and benzamidine greatly reduced this
proteolysis. However activity was still extremely labile.
3.8.4 NAD+ Affinity Chromatography
The final step involves binding of cysteine dependent activity to a dye ligand.
The commercially available dyes have often been used for the purification ofNAD(H)
or nucleotide binding enzymes, eg malate dehydrogenase, citrate synthetase and
adenylate kinase. Blue Sepharose was used successfully to purify the NAD+: cysteine
ADP-ribosyltransferase from human erythrocytes76,77, however an orange dye (Matrex
orange) was found to have better binding characteristics for the bovine cysteine
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dependent NAD'ase. The small volume of gel matrix used acts as a concentrating
step, reducing the 30 mL of dilute activity, from the cysteine sepharose column, to
1.5 mL. Good recovery of activity applied to the column was routinely obtained (70 -
90%). The protein concentration was estimated from the absorbance at 280 nm.
Separation of the purified fraction on 12% SDS polyacrylamide gel showed a single
band with silver staining. A molecular mass of 45 kDa was estimated by comparison
with the relative motilities of known molecular weight standards. This is higher than
may have been expected. Previously purified endogenous ADP-ribosyltransferases
had reported molecular weights of 28 kDa, similar to that of the SI and A protomer
catalytically active subunits of pertussis toxin and cholera toxin respectively. This
suggests that a novel cysteine dependent NAD'ase has been purified.
3.8.5 The Three Step Purification Procedure
The three step purification procedure described has successfully isolated a
cysteine dependent NAD'ase from bovine erythrocytes. The fold purifcation (47,500)
and recovered protein (20-50 /zg) are comparable to those quoted by Tanuma et al.76,77
for his prolonged five step purification of a NAD: cysteine ADP-ribosyltransferase
from human erythrocytes (fold purification 35,000; protein 20-30 /zg). After two
steps, the major contaminating protein, haemoglobin was completely removed, and
also the non-specific NAD'ase and cysteine dependent NAD'ase activity were
resolved. The most important factor leading to the success of this purification
procedure came from stabilising the enzyme activity. The addition of ethylene glycol
and protease inhibitors and the finding of storage conditions which minimised loss of
activity were contributing factors. No enzyme activity was recovered in the absence
of ethylene glycol. The protein recovered from cysteine sepharose was very dilute
(0.02-0.05 mg/mL), and in this form it was highly susceptible to proteolysis. The
addition of protease inhibitors was essential to prevent this. The purified enzyme
could be stored without loss of activity for up to three months in the presence of 30%
ethylene glycol, 0.5 M NaCl. The presence of 10 mM cysteine or 0.01% 2-
mercaptoethanol caused the loss of enzyme activity. The activity was also less stable
in the absence of high salt concentrations. Time is another important factor. 50% loss
of activity in 3.5 h on storage at 4°C was observed. Minimising the time taken to do
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the preparation and storing the ammonium sulphate pellet at -16°C until required
greatly improved activity yields.
3.8.6 Polyclonal Antibodies raised in mice
A disappointing result was obtained for the reactivity of the polyclonal
antibodies raised in mouse with the antigen on Western blot analysis. Antibody
recognition was apparently blocked by denaturation. Dot blot analysis of native and
denatured cysteine dependent NAD'ase showed strong antibody recognition with the
native protein only. The small peptide products used were probably not ideal
immunigens. A good immunogen has three propeties. One, its epitope must be
recognised by cell surface antibody found on B cells. Two, it must have a site which
may be recognised simultaneously by Class II and T cell receptors. Three, it must
be degradable. The chances of a good immune response are improved by optimizing
phagocytosis conditions. In this protocol Freunds complete adjuvant was used to trap
the antigen and stimulate host immune response. Alternatively, the antigen could have
been modified by linking it to a carrier or using nitrocellulose bound material133,134.
Raising antibody against denatured protein bound to nitrocellulose may give a positive
result on subsequent Western blot analysis.
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comparison of NAD glycohydrolase activities
of Pertussis toxin and Cysteine Dependent NAD'ase
Purified from bovine Erythrocytes
4.1 Introduction
NAD glycohydrolase activity describes the hydrolysis of NAD+ by cleavage
of the N glycosidic linkage between ADP-ribose and nicotinamide (1). Enzymes
catalysing this reaction are widely distributed135. NAD glycohydrolases (E.C.
3.2.2.5.) are found in all mammalian cells and are particularly abundant in
macrophage. ADP-ribosyltransferases136, (E.C. 2.4.2.30, E.C. 2.4.2.31) catalyse the
transfer of ADP-ribose from NAD+ to an acceptor molecule with concomittant release
of nicotinamide and H+ (2), and also exhibit NAD glycohydrolase activity to some
degree in the absence of acceptor.
NAD+ + H20 * ADP-ribose + nicotinamide + H+ (1)
NAD+ + Acceptor ** ADP-ribose-Acceptor + nicotinamide + H+ (2)
NAD glycohydrolase activity can be measured easily by separation on an ion
exchange resin of [3H]nicotinamide released from [3H]NAD+. Although this assay
does not distinguish between the above reactions it has been extensively used for
kinetic studies of both bacterial protein toxins and endogenous ADP-ribosyl¬
transferases. The reaction is generally regarded as a model to analyse the initial
events in the enzymatic mechanism of ADP-ribosylation.
The cloning of the pertussis toxin operon was achieved independently by two
groups10,11. Site directed mutagenesis and the study of deletion mutants has advanced
the knowledge of structure function relationships of SI greatly, but the catalytic
mechanism is still poorly understood (this is discussed in detail in section 1.2.3).
Important residues have been identified which are essential for NAD'ase activity in
pertussis toxin. These are Arg-9, Trp-26, His-35, and Glu-129137. The first three
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form part of two regions of eight amino acids long which are homologous to cholera
toxin A protomer which has been postulated to form part of a common N-terminal
NAD+ binding site.
Glu-129 has been shown to be involved in catalysis. Photoaffmity labelling
of pertussis toxin resulted in covalent binding of the labelled nicotinamide moiety of
NAD+ to Glu-129138. Deletion or replacement of Glu-129 with apartic acid resulted
in a drastically reduced enzymatic activity but had little effect on the binding of
NAD+139. The role of glutamate in the catalytic mechanism is a matter of some
debate. It may serve as a general base to deprotonate the ADP-ribosyl acceptor
substrates or it may stabilize an oxocarbonium ion transition state intermediate of
NAD+ in the active site. A catalytically important glutamate residue is observed for
other bacterial toxins namely Glu-148 and Glu-553 of diphtheria toxin140 and
pseudomonas exotoxin A141 respectively. It seems that the amino-acid residues
involved in the catalytic mechanism are conserved amongst the ADP-ribosylating
toxins despite low degrees of significant similarity in the primary amino acid
sequence. In the absence of any sequence data concerning the endogenous ADP-
ribosyltransferases, it is interesting to speculate whether these same residues will be
conserved for these mammalian enzymes.
Pertussis toxin is inactive in the absence of reducing reagent. Examination of
the crystal structure of pertussis toxin shows that reduction of the disulphide bridge
between cysteine-41 and cysteine-200 opens up the NAD+ binding site and allows the
access of the substrate to the active site16. Activation procedures which involved
incubating pertussis toxin with 100 mM DTT for 3 hours were originally described
to activate the toxin142. These harsh conditions were required to reduce intra-subunit
disulphide bonds, resulting in a conformational change which allowed the release of
the SI subunit from the B oligomer. Later, activation of the toxin was found to be
promoted by ATP and detergent eg. CHAPS143 by promoting the dissociation of the
SI subunit from the B oligomer144 and stabilising the SI subunit in solution. The
addition of these agents allowed much lower concentrations of DTT (10 mM) and
shorter incubation times (10 min) to be employed. Kaslow et al.22 demonstrated that
membrane lipids and cellular concentrations of glutathione and ATP would be
sufficient to activate the ADP-ribosyltransferase activity of pertussis toxin in the cell.
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However, following this activation procedure, maximal NAD glycohydrolase activity
still required the presence of high concentrations of DTT (250 mM), far higher than
would be expected for reduction of a disulphide bond.
The role of thiol compounds in the NAD'ase activity of pertussis toxin may
be two fold. They may, not only, activate the enzyme by reduction of a disulphide
bond in the SI subunit, but also, they may act as an acceptor for ADP-ribose, thus
behaving as a substrate. Lobban and van Heyningen121, in this laboratory, showed
that cysteine did indeed show substrate like behaviour, although it had a very low
affinity (Km= 100 mM), and were able to isolate a product on HPLC which contained
both cysteine and ADP-ribose. Treatment of this ADP-ribosyl-cysteine compound
with phosphodiesterase released 5'AMP, leading them to conclude that cysteine was
an acceptor for ADP-ribose. As an extension to this work the ability of other small
thiol containing compounds to behave as substrates and exhibit much higher affinity
for pertussis toxin was investigated. This approach is analogous to the model assay
system developed for cholera toxin145, where arginine-methylester and other gaunidino
containing compounds were found to be acceptors for ADP-ribose.
Another approach taken was to mimic the site of ADP-ribosylation of Gs a,
the protein substrate of pertussis toxin. This C-terminal region is essential for ADP-
ribosylation. The C-terminal cysteine is the site of ADP-ribosylation9, and ADP-
ribosylation of Gj 0 is sensitive to mutations in three out of the four C-terminal amino
acids. Substitution of a glycine residue adjacent to the cysteine for apartic acid or
deletion of the the last two terminal amino acids has been shown to block ADP-
ribosylation of G, a146. Synthetic fragments derived from this region may mimic
functional aspects of this domain. A hexamer and dodecamer peptide of the C-
terminal of G, a were synthesised and tested for their ability to act as acceptors for
ADP-ribose.
Since this work was undertaken, McDonald et al.147 have reported that the
ADP-ribosylcysteine product identified on HPLC may have been generated non-
enzymatically. They proposed that the amino group of cysteine could react with the
anomeric carbon of free ADP-ribose generated in the assay by the NAD
glycohydrolase activity of pertussis toxin. The carbinolamine produced undergoes a



















The Possible Enzymatic and Non-enzymatic, ADP-ribose and Cysteine Containing Products
from the Incubation of Pertussis Toxin with NAD+ and Cysteine.
The structure of this product was confirmed by 'H NMR.
Following the investigation of thiol reagents as substrates for pertussis toxin
a study of the kinetic properties of the cysteine dependent NAD'ase purified from
bovine erythrocytes was made. This was carried out to confirm that a "pertussis
toxin-like" activity rather than a "cholera toxin-like" activity had been purified, ie
the enzyme would have a high affinity for NAD+ and cysteine would be able to act
as an acceptor for ADP-ribose, but not arginine or any other amino acid. The
substrate affinity ofNAD+, cysteine and other compounds were found and compared
to those of pertussis toxin and other known ADP-ribosyltransferases or NAD'ases.
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4.2 Alternative Thiol Substrates for Pertussis Toxin
4.2.1 Method
Cysteine methylester, S-carboxymethylester, cys-gly dipeptide and glutathione
(all purchased from Sigma), are derivatives of cysteine which were tested using the
standard NAD'ase assay procedure described in section 2.3. Compounds with thioi-
containing ring structures mercapto-benzamide, mercapto-pyridine and mercapto-
benzamidine were also tested. All solutions were made fresh and de-gassed to prevent
oxidising reactions. The C-terminal hexapeptide and dodecapeptide of G;a were
synthesised in collaboration with Professor Ramage's group (University of Edinburgh,
Centre for Molecular Recognition, Dept. Chemistry, Kings Buildings, Edinburgh).
Only 10 mg of each peptide was synthesised using an automated peptide synthesiser
(Applied Biosystems). A maximum of 1 mM was added to the NAD'ase assay.
Direct modification of the peptide by ADP-ribose was identified by HPLC.
4.2.1.1 ADP-ribosylation of Peptide: Incubation
1 mg dodecamer or hexamer were incubated in a total reaction volume of
300 /xL containing 50 mM potassium phosphate buffer, pH 7.2, 100 /xM [Adenine-2,8-
3H]NAD+ (0.1 Ci/mmole, 30,000 cpm), 1.5 mg BSA, 0.3% CHAPS, 30 /xM ATP
and 20 mM DTT for 18 hours at 30°C. Each reaction was repeated in duplicate in
the presence and absence of 10 /xg pertussis toxin. The reaction conditions described
would allow as little as 0.02% of the modified peptide to be detected from the counts
associated after separation of the products on a HPLC reverse phase column.
4.2.1.2 Identification ADP-ribosyl-Product using HPLC
After the incubation pertussis toxin and BSA were removed from the reaction
mix by filtration of the products through a membrane with a cut-off Mr 10,000
(Amicon microconcentrator). The products of the NAD glycohydrolase assay were
separated out on an ODS-HYP 2734 (Highchrom) reverse-phase column using Altex
equipment as described in section 2.4. Ideally, the relative retention times of the
charged nucleotides on the reverse-phase support are maximised by the use of a
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quarternary ammonium "solvophobic ion". For the purposes of this experiment,
potassium phosphate buffer was used instead of ammonium phoshate. Ammonium
phosphate was found to react with the orf/20-phthaldialdehyde (OPA) reagent used to
detect the peptide. The change of buffer did not effect the elution times of NAD+
and ADP-ribose standards (11.2 min and 5.2 min respectively). The optimum
running conditions, for separation of the products was 1 mL/min, 1000 psi. NAD
and ADP-ribose were eluted isocratically and detected at 245 nm. A 10 - 100%
methanol gradient was then applied to elute the peptide.
4.2.1.3 Detection of Peptide
Both the peptide and the nucleotides present had high relative absorbances at
the wave length of detection, 245 nm (Xmax 220 nm and 260 nm respectively). The
presence of peptide was identified by modification of the a amino group using
OPA148. This reagent reacts with a amino group of the peptide in the presence of 2-
mercaptoethanol at pH 10 to form a highly fluorescent isoindole compound (A„cilatl0n
360 nm and Aemission 455 nm) which may be detected using a fluorimeter (Perkin Elmer
MA-3000). OPA was chosen in preference to other modifying reagents such as
ninhydrin (less sensitive) or phenylisothiocyanate PITC (absorbs 254 nm). A 0.8 g/L
stock solution of OPA was made in 0.1 M borate buffer, 0.02% 2-mercaptoethanol,
pH 10. 0.2 mL fractions collected from HPLC were diluted to 3 mL with OPA and
allowed to react at room temperature for 20 min. Detection of nanomolar quantities
of peptide was possible.
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Time (min)
Figure 4.1 Time Course of Pertussis Toxin Catalysed NAD'ase Activity.
The nicotinamide released by the action of 20 pg pertussis toxin in the presence of 0
(O), 10 (■) and 100 mM (□) dithiothreitol was measured using the NAD'ase assay
described in section 2.3.
4.2.2 Results
Before kinetic analysis of the potential substrates was investigated the time
course of the pertussis toxin catalysed NAD'ase activity was determined. Conditions
were found where the reaction was linear over the time course of the reaction and the
maximum amount of hydrolysis of NAD+ was limited to 20% of the total NAD+
present in the assay. Figure 4.1 shows the release of nicotinamide with time by 20 pg
of activated pertussis toxin (activated as described in section 2.2) in the presence of
100 mM DTT, 10 mM DTT and absence ofDTT. The reaction was linear over a 180
min time period, beyond which the substrate became limiting. An incubation time of
90 min was chosen and was used routinely in subsequent experiments.
4.2.2.1 Apparent Substrate Kinetics
The rate of nicotinamide release catalysed by pertussis toxin in the presence
of 0-500 mM concentrations of the potential substrates was tested. Cysteine,
cysteinemethylester, cysteine-glycine dipeptide, glutathione and dithiothreitol all
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showed substrate-like kinetics, ie the rate of nicotinamide released became saturating
for increasing concentrations of compound added. The data were fitted to the
Michaelis-Menten equation using non-linear least squares curve fitting (section 2.3.3).
A linear transfomation of the data in the form of the Hanes plot ([S] versus [Sj/V) are
shown for each compound in Figure 4.2 through to Figure 4.6. The units for these
plots were millimolar concentrations of thiol substrate on the x-axis, and lxlO9 min.L"1
substrate over rate on the y-axis. The data shown is a single data set representative
of three separate experiments in which the parameters determined (Km and VmHX) varied
within 10% of each other. The standard error shown for each parameter is a measure
of the goodness of fit of the data for the Michaelis-Menten equation and not the error
between experimentally determined values.
The apparent Km and Vnmx values calculated are summarised in table 4.1. The
cysteine-like structures showed similar apparent Km values of 100 mM, however the
presence of a free sulphydryl group was essential for apparent substrate kinetics to be
observed; S-carboxymethyl-cysteine was inactive. The sulphur containing ring
systems of mercapto-pyridine and mercapto-imidazole were also inactive; no increase
Cysteine (mM)
Figure 4.2 Hanes Plot for Cysteine from which a Km of 109+ 30 mM, and Vmax of
55 + 5 pmol min"1 was estimated.
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Cysteine methylester (mM)
Figure 4.3 Hanes Plot for Cysteinemethylester from which a Km of 116+25 mM,
and of 50+5 pmol min1 was estimated.
eys-gly peptide (mM)
Figure 4.4 Hanes Plot for Cys-Gly Dipeptide from which a Km of 90+19 mM,
and V^ of 56+5 pmol min1 was estimated.
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Glutathione (mM)
Figure 4.5 Hanes Plot for Glutathione from which a Km of 20+3 mM, and Vmax of
25 + 3 pmol min"1 was estimated.
Dithiothreitol (mM)
Figure 4.6 Hanes Plot for DTT from which a Km of 9+2.5 mM, and Vmax of
33 + 3 pmol min"' was estimated.
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in the rate of nicotinamide released was observed for additions of compound to a
maximum of 500 mM.
4.2.2.2 Peptide Synthesis and Confirmation
The products of both syntheses ran as single peaks on C18-reverse phase
HPLC column suggesting that a homogeneous product had been formed and no side
chain branching reactions had occurred. The correct composition was confirmed by
amino acid analysis and mass spectrophotometry. The relative proportions of each
of the amino acids was confirmed by this method and no unspecified amino acids
were present. The molecular mass of the product was compared to the theoretical
expected for the required composition. Mass spectrometry of the dodecamer showed
a single mass ion with a relative molecular mass of 1378.5 (calculated mass,
1377.69). Similarly the hexamer showed a single mass ion of 682 (calculated mass
681.82). These data were consistent with the peptides having the composition
specified:
C-terminal dodecamer of G,a IIKNNLKDCGLF
C-terminal hexamer of GjO! K D C G L F
4.2.2.3 Identification of ADP-Ribosyl Peptide by HPLC
The separation of NAD+, ADP-ribose and ATP standards by isocratic elution
from the reverse-phase HPLC column in 10 mM potassium di-hydrogen phosphate,
5 % methanol, pH 3.5 is shown in Figure 4.7. NAD+ and ADP-ribose are well
separated, and have elution times of 11.2 and 5.2 min respectively. Nicotinamide, the
product of hydrolysis of NAD+ does not absorb radiation at 254 nm (the wavelength
of detection) and therefore cannot be detected by this system. ATP is present in the
assay from the activation procedure of pertussis toxin. It is highly charged and is not
retained by the column; it is eluted at 4.0 min, after one column volume of buffer has
passed through the column. The dodecamer and hexamer peptides bind to the






Figure 4.7 Elution of NAD+, ADP-ribose and ATP Standards from ODS-HYP-
2734, Reverse Phase HPLC. Elution achieved at 1 mL/min and detected at 254 nm





Figure 4.8 Elution of Hexamer and Dodecamer Peptides from Reverse Phase




Figure 4.9 Dose Response Curves of Hexamer (■) and Dodecamer (O)
Peptides With OPA reagent
lmg each of the dodecamer and hexamer peptide was incubated with pertussis toxin
o
overnight at 30 C. The products of the assay were separated on the reverse phase
column and the elution profiles at 254 nm are shown in Figure 4.10 (a and b) and
Figure 4.11 (a and b). Fractions were collected and tested for the presence of [3H]
label, by scintillation counting, and of peptide by fluorescence detection using OPA
reagent. These data are shown in Figure 4.12 and Figure 4.13 for the dodecamer and
the hexamer peptide respectively. The reaction of OPA with peptides is dependent
upon the N terminal amino acid. It does not react with cysteine and reacts poorly
with lysine residues; the N-terminal amino acid of the hexamer. The dose reponse
curves of each of the peptides with OPA is shown in Figure 4.9. The minimum
amount of dodecamer detectible is 1 nmole, which is equivalent to 0.3 % of the total
amount of peptide added to the ADP-ribosylation assay. The minimum amount of
hexamer detected was 2 nmole, which is equivalent to 0.3 % of the total peptide















Figure4.10(b)HPLCtracofheproductsincubationwi hdodecamerndpert ssist xin.
Figure4.11(a)HPLCtracofheproductsincubationwithhex merandwithoutpertussisto in.
Elutiontime(0.5cm/min)
Figure4.11(b)HPLCtracofheproductsincubationwi hhex m randpe tussisto in.
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(a) without pertussis toxin
(b) with pertussis toxin
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fraction number
Figure 4.12 3H Counts Released (□) and Fluorescence Detection (•) of
Hexamer Peptide in the Eluate from reverse phase HPLC.
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Figure 4.13 3H Counts Released (□) and Fluorescence Detection (•) of
Dodecamer Peptide in the Eluate from reverse phase HPLC.
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ribose molecule then for 1 nmole of peptide, 2000 counts per minute would be
detected (2 cpm/pmol). Examination of Figure 4.12 shows that in the presence of
pertussis toxin and dodecamer peptide 90 % of the NAD+ is hydrolysed to ADP-
ribose during the time course of the reaction. A peak of radioactivity is observed in
fractions 24 and 25 (about 1000 cpm) in the control incubation without pertussis
toxin. A similar sized peak is observed in the presence of pertussis toxin but has
shifted in elution time and is seen in fraction 28. Neither of these fractions were
fluorogenic on reaction with OPA and further characterisation of the nature of these
peaks was not pursued. A very low level of counts was observed in fractions 31-34
in the presence of pertussis toxin, which were not evident in the control. A small
increase in the amount of fluoresence detected above background was detectible in
these fractions and was not evident in the control. This increase was at the limit of
sensitivity of the assay and could not be measured reliably. The total number of
counts associated with this fraction is equivalent to 500 pmole of ADP-ribose.
Assuming a ratio of 1:1 ADP-ribose incorporated into the peptide then this is
equivalent to 0.07 % of the total peptide. Whether this product is ADP-ribose-
dodecamer is doubtful. The product was not detected after shorter incubation times
(3 - 8 h) or for incubations with ten fold less NAD+ (0.1 mM instead of 1 mM). It
is possible that it was generated non-enzymatically in the presence of excess ADP-
ribose, generated by the NAD glycohydrolase activity of pertussis toxin, during the
prolonged incubation overnight.
Examination of Figure 4.11 shows that in the presence of hexamer and
pertussis toxin NAD glycohydrolase was inhibited. Only 10 % of the total NAD+ has
been hydrolysed under conditions where complete hydrolysis may have been expected
(as seen in incubations with the dodecamer peptide). No putatative ADP-ribose-
hexamer containing fractions were detected. The ability of the peptides to inhibit the
NAD glycohydrolase assay was tested further by adding 0-0.5 mM concentrations
of peptide to the NAD glycohydrolase assay. The results are shown in Figure 4.14
and Figure 4.15 for the dodecamer and hexamer peptides respectively. 50 %




Figure 4.14 Inhibition of NAD'ase Activity by Dodecamer Peptide. 50%
inhibition is observed at 0.19 mM concentration of peptide.
Hexamer (mM)
Figure 4.15 Inhibition of NAD'ase Activity by Hexamer Peptide. 50% inhibition
is observed at 0.2 mM concentration of peptide.
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Table 4.1 Summary of Alternative Substrates for Pertussis Toxin
Substrate Kn (mM) Vmax relative Vmax'Km g ' 149
Dithiothreitol 9+2.5 1 35 -0.33
cysteine 109+30 1.72 0.48 -0.22
S-carboxymethyl-
cysteine
- - - -
cysteine-methylester 116+25 1.46 0.42 -0.22
cys-gly 90+19 1.75 0.44 -0.22
glutathione 20+3 0.81 1.5 -0.24
mercapto-pyridine >500 - -
mercapto-imidazole >500 - - -0.06
hexamer 0.2 50% inhibition
dodecamer 0.19 50% inhibition
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4.2.3 Discussion
The small molecule free thiol containing compounds tested all showed apparent
substrate kinetics. In the table 4.1 above the Km value gives a measure of the affinity
of the substrate for pertussis toxin and Vmax/Km gives a measure of the specificity of
the substrate. DTT showed the highest specificity of all the substrates tested. It had
the highest affinity (Km— 5 mM) and a maximal rate of 33 pmol.min'. The cysteine
like substrates containing a free thiol group showed similar specificity values to each
other (Km = 100 mM, 55 pmol.min1). This suggests that neither binding nor
catalysis were sensitive to the negative charge on the carboxyl group. Larger
structures such as glutathione showed a five fold increase in affinity compared to
cysteine, but was reduced such that the specificity of the substrate was low
compared to DTT. No substrate affinity was found at all for the hexamer and
dodecamer peptides, although tight binding affinity was suggested from the observed
inhibition of NAD'ase (50 % inhibition at 0.2 mM ). The aromatic thiol containing
compounds had no effect on the NAD glycohydrolase activity of pertussis toxin.
They were niether substrates, nor inhibitors of the toxin.
One interpretation of these data assumes that the apparent Michaelis-Menten
kinetics observed is due to the thiols acting as acceptors for ADP-ribose and
competing with water at the active site. The small thiol compounds are free to enter
the active site of the enzyme and may dissociate readily. Maximal catalysis is
observed. Glutathione binds more tightly than cysteine to the enzyme but is not quite
the right conformation to readily accept ADP-ribose. Its presence at the active site
blocks hydrolysis by water and reduced Vmi are observed. This effect is taken to the
extreme in the presence of hexamer and dodecamer peptide. Effective binding is
achieved but no turnover of the substrate occurs.
It was disappointing that no effective substrate mimic was found. Although
the C-terminal amino acid composition is important for ADP-ribosylation of G,a it
appears that it is not sufficient on its own to act as an acceptor. Perhaps a longer
peptide is required to achieve the correct folding or possibly distant portions of the
GjO! are essential for the correct protein protein interactions. Studies with ots and a,
G protein chimeras confirm that the C-terminal portion is not sufficient for ADP-
ribosylation by pertussis toxin150. It is also known that efficient ADP-ribosylation of
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Gjo; requires the interaction of the By subunits151. It is perhaps not so surprising that
the peptides were able to interact with the toxin, causing inhibition of the NAD
glycohydrolase activity but fail to act as substrates for ADP-ribosylation.
Since this work was completed Graf et al.152 have made a comprehensive study
of the inhibition of ADP-ribosylation of G.c* by C-terminal synthetic peptides of 10-20
amino acids in length. The longer the peptide the greater the inhibition of ADP-
ribosylation of Gj that was observed. This trend was not seen for the dodecamer and
hexamer, in their ability to inhibit the NAD glycohydrolase assay. Interestingly, Graf
et al. observed that the C20 peptide was ADP-ribosylated, and they developed an
assay to determine the kinetics parameters for several C-terminal peptides.







C-15 G,i find Gi2 TDVIIKNNLKDCGLF 480 15
C-15 Ga TDVIIKNNLKECGLY 120 42
The assay involved the TCA precipitation of the peptides onto glass fibre
filters, and the amount of [32P] incorporated was counted using a scintillation counter.
The reaction conditions were sub-saturating for NAD glycohydrolase activity (20 /xM
NAD+) and carried out for 3 h at 4 C. The use of low concentrations of [32P]NAD+
made this assay system 100 times more sensitive than the HPLC detection system
used in the experiment described above. However the results should be treated with
some caution since non-specific labelling may be detected using the filter binding
87
assay, and direct evidence for the modification of the peptide by ADP-ribose was not
demonstrated. The data showed that small changes in the amino acid composition
could produce a four fold difference in the affinity of pertussis toxin for peptides of
the same length. The C- 15 amino acids of Gil/2a have Km value of 480 /xM, whereas
the C-15 amino acids of Gi3a, in which asp-250 is changed to glu and phe-254 is
changed to tyr, have a Km 120 /xM.
From table 4.2 the reasons why the dodecamer and hexamer synthesised were
poor substrates for pertussis toxin become apparent. Unluckily, the dodecamer is too
short and corresponds to the sequence which has a reduced substrate specificity for
pertussis toxin.
An alternative explanation for the apparent substrate kinetics observed for the
small thiol containing compounds may be based on the extent of reduction of the
toxin.
kf |RSH] kcat
Ej ** Ea -* Products
K
This model proposes that when the enzyme is incubated with reducing reagent
[RSH], the interconversion rate of active and reduced toxin (Ea) and inactive oxidised
toxin (E,) is described by the reversible equilibrium reaction above. In the absence
of reductant all of the enzyme will be in the inactive form. Reductant is required to
maintain the enzyme in its active form. Removal of the reductant after activation will
result in the rapid re-equilibration to the inactive form.
The total amount of enzyme E0 present is
(1)
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and the amount of active enzyme present in the steady state will be defined by
Ea = ; kf[RSH] EaK (2)
therefore, by substitution equation (2) in equation (1)
E0 =Ea 1 + 2lU&
kf [RSH]
(3)
The rate of product formation obsereved, Vobs is defined by Ea.kcal. Substituting the
equation (3) into this formula shows that the rate observed will vary as a rectangular
hyperbole with respect to the concentration of reductant.
y Ka, Ec [KH]
kf [RSH] +( 1 t k,)
This is the same expression as the Michaelis Menten equation for which the
data were a good fit. If the toxin is highly sensitive to oxidation and rapidly
inactivates in the absence of high concentrations of DTT then the apparent substrate
kinetics observed may be a function of activation. The Km observed will be the
concentration of reductant required to half maximally activate the toxin, i.e. the
condition where half the enzyme is reduced ([Ei\ = [Ea\ in the model). The
concentration of reductant required to maintain the toxin in the half reduced state {Km
observed) will be dependent on how good a reductant is the compound. The standard
electrode potential (E0') is a measure of reducing potential; the lower the potential
the better the reducing power. From the Nernst equation, the higher the standard
electrode potential is for a compound then the more of that compound will be
required to maintain a given potential. Figure 4.16 shows the plot of E0' versus Km
observed for DTT, glutathione and cysteine and confirms the expected trend.
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-0.36 -0.26 -0.16 -0.06
Standard Electrode Potential Eo
Figure 4.16 The Dependence of Km observed on the Standard Electrode
Potential of the Substrate
For this model to be true, then the equilibrium is in favour of the inactive
form of the enzyme. High concentrations of reductant are required to push the
equilibrium towards the active form of the enzyme and maintain the enzyme in the
active form. Activation of pertussis toxin with 100 mM DTT and subsequent removal
of the reductant by dilution results in less than maximal NAD'ase activity being
observed, even when precautions have been taken to minimise oxidation reactions.
The high concentrations of reductant required and the rapid inactivation of the enzyme
in the absence of oxidants are unusual properties of a redox system. These factors
and the fact that the Vmax observed for each reductant tested was not the same, suggest
that the apparent substrate kinetics observed are not simply a function of reduction of
the enzyme.
In the above experiments the thiol compounds are probably functioning as both
acceptors and activators of the enzyme. The assay measures nicotinamide release and
does not give any indication of the proportion of ADP-ribose to ADP-ribose-acceptor
generated. Clarification of the kinetic processes involved requires the development
of an assay which differentiates ADP-ribose and ADP-ribose-acceptor directly. This
is beyond the scope of this thesis.
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4.3 Kinetic Properties of Cysteine Dependent NAD'ase
4.3.1 Time Course
A modification of the NAD'ase assay described by Moss and Vaughan was
followed as described in section 2.3. The assay allows single time point
measurements. For valid kinetic analysis, conditions must be found where NAD+




Figure 4.17 Time Course of Reaction of the Cysteine Dependent NAD'ase
The amount of nicotinamide released at given time intervals was measured in the
presence (■) and absence (O)of enzyme
The NAD'ase assay was set up to contain saturating levels of subtrates. At
given time intervals the reaction was stopped by application of the reactants onto the
DOWEX resin. The amount of nicotinamide released was calculated and is shown
in Figure 4.17. 30% of the total NAD+ is used up in 30 minutes and is linear over
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this time period. Extended incubation times, beyond 30 minutes did not release any
more nicotinamide. This could be due to product inhibition or inactivation of the
enzyme, which is very labile (see section 3.4). Non-enzymatic breakdown of NAD+
over the time course is also shown. 8% of total NAD+ at time zero increased to 15 %
over the time course of the experiment. Some hydrolysis of the NAD+ stock had
occurred on storage at pH 5.0, 4°C. The NAD'ase assay is performed at neutral pH
and in the presence of phosphate ions and thiol reagents, all of which are known to




The effect of pH on the maximal rates of NAD'ase activity were studied. 1 M
stock solutions of monobasic potassium phosphate, dibasic potassium phosphate,
sodium citrate, Tris base and 10 M HC1 were made. The stock solutions were mixed
together to give the required pH (calculated from the Henderson-Hasselbach
equation). Phosphate buffer pH 6.0 - 8.0, citrate phosphate pH 5.0 - 6.6, Tris-HCl
pH 7.4 - 9.0 were checked using a pH meter (Corning). NAD+-glycohydrolase
reactions were set up to contain 50 mM prepared buffer, 100 mM cysteine (made
fresh and adjusted to neutral pH), 100 /xM [3H]NAD+ and activated pertussis toxin
or cysteine dependent NAD'ase. The enzymes were dialysed against low ionic
strength buffer and control incubations containing an equal volume of dialysis buffer
(or of activation mix for pertussis toxin) for each enzyme was performed. The
reaction was stopped by the addition of 0.85 mL ice cold 50 mM Tris-HCl pH7.4.
This buffers the incubation mixtures, such that the binding properties of NAD+ to the
ion exchange column are not effected. The amount of released nicotinamide produced
was detected by scintillation counting.
4.3.2.2 Results
Figure 4.18 and Figure 4.19 show the pH profiles obtained under the assay
conditions described for cysteine dependent NAD'ase and pertussis toxin respectively.
Background and enzymatic rates of nicotinamide released are shown. As expected154,
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pH
Figure 4.18 pH Optima Curve for Cysteine Dependent NAD'ase.
Incubations containined phosphate buffer with (•) and without (O) enzyme or Tris
bufffer with (■) and without (□) enzyme.
PH
Figure 4.19 pH Optima Curve for Pertussis Toxin.
Incubations containined phosphate buffer with (•) and without (O) enzyme
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at neutral and alkali pH the rate of backgound hydrolysis increased; this was most
prominently observed for incubations with pertussis toxin which were run for 90 min.
Both the endogenous enzyme and pertussis toxin show a characteristic bell shaped
curve with pH optima pH7.4 - 7.6 at saturating concentrations of substrates. Control
incubations were set up to check that denaturation of the enzymes at the high and low
pH tested did not occur. The enzymes were incubated in buffer at pH 5.5 or pH 8.6
(15 min for the endogenous enzyme and 60 min for pertussis toxin) and then were
assayed at maximal conditions (pH 7.4) and compared to untreated enzyme. No loss
in activity was observed as a result of these pre-treatments, confirming that the
change of activity observed over the range of pH tested was not due to denaturation
of the enzymes.
Potassium phosphate buffer appears to activate the endogenous enzyme. Two
fold higher activity was observed in the presence of phosphate compared to Tris-HCl
at the same pH. Half maximal activity observed on the descending portion of the bell
shaped curve for the cysteine dependent NAD'ase is observed at pH 8.1; this is close
to the pKa of the thiolate ion of free cysteine. The thiolate ion is a highly reactive
nucleophile and at neutral pH values and above cysteine rapidly oxidises to cystine154.
This modification of the acceptor substrate may account for the rapid loss in apparent
activity.
4.3.3 NAD+ Dose Response Curve
4.3.3.1 Method
NAD'ase activity was assayed as described in section 2.3. Incubations were
set up containing 50 mM potassium phosphate, pH 7.4 and NAD+ in the range 0 -
0.25 mM. Assays containing low concentrations of [3H]NAD+ (below 20 /xM) were
performed using a high specific activity [3H]NAD+ stock solution (1 Ci/mmole, 10
cpm/pmole) in order that significant counts could be detected. Pertussis toxin assays
were performed in the presence of 250 mM DTT. Endogenous cysteine dependent
NAD'ase assays were performed in the presence of freshly prepared 100 mM




Figure 4.20 Hanes Plot of NAD+ as a Substrate for Cysteine Dependent
NAD'ase. Km of 8 fiM and of 300 pmol-min1 was estimated.
NAD (yM)
Figure 4.21 Hanes Plot of NAD+ as a Substrate for Pertussis Toxin.




The dose response curves obtained were fitted to the Michaelis-Menten
equation using non-linear least squares curve fitting (see section 2.3.3). The Hanes
plot of the data are shown in Figure 4.20 and Figure 4.21 for cysteine dependent
NAD'ase and pertussis toxin respectively. A Km of 30 fxM and of 37.5
pmol.min 1 was found using this method for pertussis toxin and a Km of 8 /iM and
V'no, of 300 pmol min1 was found for the endogenous cysteine dependent activity.
4.3.4 Cysteine: A Substrate of Cysteine Dependent NAD'ase
In chapter three it was seen that the enzyme was inactive in the absence of
cysteine. Here the affinity of cysteine for the enzyme and its ability to act as an
acceptor for ADP-ribose was tested.
4.3.4.1 Method
NAD glycohydrolase assays were set up containing 50 mM potassium
phosphate, pH 7.4 and 100 fiM (3H-nicotinamide)NAD+. A 1 M stock solution of
cysteine (free acid) was prepared fresh and neutralised with sodium hydroxide. All
solutions were degassed to minimize oxidation reactions. Cysteine was added in the
range 0 - 250 mM to the assay. The reaction was started by the addition 100 ng
cysteine dependent NAD'ase and was incubated for 20 min at 30 C.
The reaction was repeated at saturating conditions of (3H-Adenine)NAD+
(100 fiM) and cysteine (100 mM). After incubating for 30 min the reaction was
stopped by cooling on ice. The cysteine dependent NAD'ase was removed by
filtration through a 10,000 Mr cut-off membrane and the filtrate was applied to the
reverse-phase HPLC column as described in section 2.4. The products of the
NAD'ase assay were separated on the column by isocratic elution in 10 mM
ammonium phosphate buffer, pH 3.5, 10 % methanol. 0.5 mL were collected and
the amount of 3H label contained in each fraction was measured by scintillation
counting.
A putatative ADP-ribosyl-cysteine product was collected. To confirm the
presence of an ADP-ribosyl cysteine linkage the product was treated with snake
venom phosphodiesterase (from Crotalus durissus terifficans) following the
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methodology of Lohban and van Heyningen145. The product was incubated with
20 jiig/mL of phosphodiesterase in 50 mM potasium phosphate pH 7.5 for 5 h at
37 °C. The enzyme was removed by filtration through a 10,000Mr cut-off membrane
and the filtrate was applied to the reverse phase column.
4.3.4.2 Results
Cysteine (mM)
Figure 4.22 Hanes Plot of Cysteine for the Cysteine Dependent NAD'ase. A
Km of 4.4 mM and of 300 pmol.min 1 was estimated.
The dose response curve obtained for cysteine for the cysteine dependent
NAD'ase was fitted to the Michaelis-Menten equation using non-linear least squares
curve fitting and the linearised form of the data are shown as the Hanes plot in
Figure 4.22. Apparent substrate kinetics for cysteine were observed, and a Km value
of 4.4 mM was calculated.
Separation of the products of the NAD'ase assay on ODS-HYP reverse phase




Elution time (0.75 cm/min)
Figure 4.23 Separation of the Products of the Cysteine Dependent NAD'ase
Catalysed Reaction on Reverse Phase HPLC. Reactionss contained 100 mM
cysteine, 100 /xM [3H]NAD+ and were incubated for 15 min at 30°C without (a) and
with (b) the enzyme.
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by isocratic elution in 10 mM ammonium phosphate pH 3.5, 10 % methanol. Elution
times of 4.8 min for ADP-ribose and 7.5 min for NAD+ were consistent between
runs. Incubations which contained cysteine and cysteine dependent NAD'ase showed
little change in the size of the ADP-ribose or NAD+ peaks detected at 254 nm. A
second peak was observed at 5.5 mins, and was found to contain 3H label
(Figure 4.24). This is in a similar position to the putatative ADP-ribosylcysteine
product described for pertussis toxin by Lobban and van Heyningen. Treatment of
this novel peak with phosphodiesterase yielded a new 3H labeled peak at 16.6 min,
coincident with the AMP standard as shown in Figure 4.25.
0 2 4 6 a 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40
fraction number
Figure 4.24 Counts Detected in the Eluate from the Separation of the Products
of the Cysteine dependent NAD'ase Assay on Reverse Phase HPLC, with (•)





Figure 4.25 Phosphodiesterase Treatment of the Putative ADP-ribosyl-
cysteine product. The putative ADP-ribose containing compound (a) was treated with
phosphodiesterase and the products of the reaction were separated by reverse phase
HPLC (b). The major product released was compared to an AMP standard (c) run
under comparable conditions 1 ml/min, 2.67 cm/min.
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4.3.5 Substrate Specificity of Cysteine Dependent NAD'ase
Is the reaction amino-acid specific or can any amino-acid act as an acceptor
eg arginine? Can cysteine be susbtituted for any thiol containing compound and if so,
is cysteine an acceptor or an activator? To answer these questions NAD'ase assays
were set up containing saturating levels of NAD+ (100 j*M), 50 mM potassium
phosphate buffer, pH 7.4 and 100 ng of cysteine dependent NAD'ase. Nicotinamide
released in the presence or absence of potential substrates (100 mM
argininemethylester, 100 mM glycine, 100 mM cysteine, 100 mM dithiothreitol and
100 mM S-carboxymethylester cysteine) was then determined.
4.3.5.1 Results
The NAD'ase activity observed in the presence of potential substrates is listed
in table 4.3. No activity was observed with arginine methylester, glycine or S-
carboxymethylester cysteine. A dose response curve for dithiothreitol shows that like
cysteine apparent substrate kinetics were observed. The data were fitted to the
Michaelis-Menten equation using non-linear least squares curve fitting and are shown
in Figure 4.26 as the Hanes plot. A Km value of 0.1 mM was calculated. This was
40 fold lower than that observed for cysteine. DTT is a powerful reducing reagent.
The difference in apparent Km between cysteine and DTT may reflect this property.
30% of the maximal activity observed with cysteine was observed in the presence of
DTT. Pre-incubation of the cysteine dependent NAD'ase with 10 mM DTT did not
effect the apparent substrate kinetics observed for cysteine; a Km 4 mM was observed.
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Dithiothreitol (mM)
Figure 4.26 Dose Response Curve of Dithiothreitol for Cysteine Dependent
NAD'ase. Km of 0.1 mM and of 87 pmol/min1 was estimated.
Table 4.3 Substrate Specificity of Cysteine Dependent NAD'ase
Substrate Km (mM) Vmax (pmol/min)
cysteine 4 300
arginine-methylester >100 not detectible








Comparison of thq time courses shown in Figure 4.1 and Figure 4.17 for
pertussis toxin and cysteine dependent NAD'ase respectively shows that 30% of the
total NAD+ is hydrolysed by pertussis toxin in 180 min, compared to 15 min for the
cysteine dependent NAD'ase. One hundred fold more protein was required for the
pertussis toxin catalysed reaction compared to the mammalian catalysed reaction. The
pertussis toxin reaction was linear until 50% of NAD+ had been hydrolysed, and was
stable at 30°C. The cysteine dependent NAD'ase was linear until 30% of the total
NAD+ had been hydrolysed, and was less stable. Incubation of the cysteine
dependent NAD'ase for longer periods proved unsuccessful. The rate of nicotinamide
release became non-linear after 30 min, even if NAD+ was still available. The
lability of the enzyme observed during the purification (chapter three) is most
probably the cause of this problem.
4.3.6.2 pH Optima
The simplest model to explain the pH optima curves observed is that at least
two ionizing groups present in the active site are able to change their state of
protonation as the pH changes. For catalytic activity to be observed only one of these
groups need be protonated. The bell shaped curve observed is steep; 1.5 pH units
separate the curves at half the maximal height. Accurate determination of the pKa of
the ionizable groups is not possible from this simple analysis. However, an estimate
of the pKg by measuring the pH at the points where half maximal activity was
observed gives plC, 6.8 for the first ionizable group and 8.1 for the second. It is
difficult to attribute specific ionizable groups to these pKa values, since the pKa will
be dependent upon the environment of the charged group within the active site. For
example, the y-carboxyl group of glutamate has a pKa of 3.9 as a free amino acid,
but has a pl^ 6.5 within the active site of lysozyme155. Site directed mutagenesis and
photoaffinity cross-linking experiments of pertussis toxin have implicated the
importance of Glu-129 and His-35 residues in catalysis. A mechanism has been
proposed where Glu-129 stabilizes an oxocarbonium ion intermediate of NAD+ and
His-35 acts as a proton acceptor for the incoming acceptor molecule156. Given the
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similarity of the pH profiles it is inviting to suggest that the catalytic mechanisms of
the two enzymes are similar with the important residues in similar environments
within their respective active sites.
4.3.6.3 Substrates of cysteine dependent NAD'ase
NAD+ had a high affinity for cysteine dependent NAD'ase: a Km value of
8 /xM was determined. This is a similar order of magnitude to the affinity of NAD+
for pertussis toxin (30 /xM) and the NAD+: arginine ADP-ribosyltransferase from
turkey erythrocytes ( 8 /xM)59. It is approximately 100 fold tighter binding than that
observed for cholera toxin (1.1 mM) and six fold tighter binding than that described
for a NAD+: cysteine ADP-ribosyltransferase from human erythrocytes (65 /xM)75.
From the Vmax observed at saturating NAD+ and saturating cysteine a kcai may be
estimated for the cysteine dependent NAD'ase. Assuming that all the protein added
is active and that the enzyme has a molecular weight of 45,000 (estimated from SDS
polyacrylamide gels) then the cysteine dependent NAD'ase has a kC(U of 30 min1.
This is 150 fold higher than the kcat of 0.2 min1 estimated for pertussis toxin
(calculated from the Mr 28,000 of the active subunit SI, rather than the whole toxin,
110,00).
Apparent substrate kinetics were observed for cysteine and aRvalue of 4 mM
was calculated. This shows a twenty fold higher specificity for cysteine than pertussis
toxin (100 mM), and a similar specificity to that exhibited by the NAD+: cysteine
ADP-ribosyltransferase (4.4 mM). The presence of the free thiol group was essential
for activity to be observed; no NAD glycohydrolase activity was observed in the
presence of S-carboxymethylester cysteine. Arginine-methylester and glycine were
not substrates, confirming that the enzyme is specific for cysteine and is free from
any contamination by NAD+: arginine ADP-ribosyltransferase. NAD glycohydrolase
was observed in the presence of DTT and a Km value of 0.1 mM was calculated.
These data sugggest that the role of thiol reagents may be two fold. Free thiol may
be required to reduce a disulphide bond in order to observe NAD'ase activity and also
act as acceptors for ADP-ribose. This is similar to the properties observed for thiol
reagents with respect to pertussis toxin, as discussed in section 4.2.3.
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Evidence that cysteine was an acceptor for ADP-ribose was suggested by the
identification of a novel ADP-ribose containing product isolated by reverse phase
chromatography. This product was eluted between ADP-ribose and NAD+ in a
similar position to that described for ADP-ribosyl-cysteine, eluted under identical
conditions by Lobban and van Heyningen145. The product was only observed in
incubations containing cysteine, NAD+ and cysteine dependent NAD'ase. From these
observations the presence of cysteine in this product was assumed. The possibility
that this product was derived from the non-enzymatic reaction of ADP-ribose and
cysteine as described by McDonald et al.147 remains. However, much shorter
incubation times were used to investigate the activity of the cysteine dependent
NAD'ase; 30 min instead of overnight incubation of the reactants with pertussis toxin.
This time period may be too short for the non-enzymatic chemistry to play a
significant role. Also, no product was observed in the absence of cysteine dependent
NAD'ase, despite the presence of significant levels of ADP-ribose (20 fiM) from the
hydrolysis of NAD+ stock solution with storage. It seems more likely that the




The work presented in this chapter investigates the ability of the purified
cysteine dependent NAD'ase from bovine erythrocyte to also catalyse the transfer of
ADP-ribose to a protein target. As discussed more fully in chapter one this reaction
was first identified during the study of the pathogenesis of diseases such as diphtheria,
cholera and whooping cough. Many of the bacterial toxins specifically modify
members of one family of proteins, the G proteins, which are important in signal
transduction pathways. Endogenous ADP-ribosyltransferase activities which
apparently modify the same target proteins have been identified, as well as a variety
of novel target proteins suggesting a ubiquitous role for mono-ADP-ribosylation in
cellular control mechanisms.
Mono-ADP-ribosylation catalysed by the bacterial protein toxins is amino acid
specific. Diphtheria toxin modifies diphthamide residue of elongation factor 2 thereby
disrupting protein synthesis. Cholera toxin modifies an arginine residue of Gsa and
pertussis toxin modifies a cysteine residue of G,a, thus in both cases disrupting the
cAMP dependent signalling pathway. At high concentrations cholera toxin has been
shown to modify a variety of proteins in vitro eg BSA157, acetyl CoA carboxylase158
and by auto-ADP-ribosylation, itself159. In these reactions ADP-ribose is always
covalently linked through an arginine residue, but are not thought to be
physiologically relevant. Pertussis toxin on the other hand is more specific, ADP-
ribosylating only the a subunit of trimeric G proteins which contain a C-terminal
cysteine residue (Q, G0, and transducin).
Endogenous ADP-ribosylation of arginine, cysteine, diphthamide, lysine,
asparagine and glutamate residues of various target proteins have been reported
(Chapter one for review). Few of the enzymes responsible have been identified, but
those that have appear to be amino acid specific, eg NAD+: arginine ADP-ribosyl
transferase from turkey erythrocytes and NAD+: cysteine ADP-ribosyltransferase from
106
human erythrocytes. It is possible therefore, that for every potential ADP-ribosylated
target there is a specific ADP-ribosyltransferase to be discovered.
Endogenous enzymes need not be present to account for all the ADP-
ribosylated protein identified. Free ADP-ribose is a highly reactive species and may
react with proteins directly by the formation of Schiffs base with lysine residues160,161.
Arginine residues in skeletal muscle cytosolic proteins have been shown to be
specifically modified by free ADP-ribose162. The glycolytic enzymes glyceraldehyde-
phosphate dehydrogenase, lactate dehydrogenase and alcohol dehydrogenase have all
been shown to be covalently modified through a cysteine residues by free ADP-
ribose114 or NAD+115 leading to inhibition of the enzymes.
Care must be taken therefore in interpreting apparent ADP-ribosyltransferase
activity. Ideally the target protein and the modified residue can be identified by
protein sequencing. Experimentally this may be difficult because the target protein
is present in such low quantities. The type of ADP-ribose-amino acid linkage can be
deduced from the stability of the radiolabel to chemical cleavage. Jacobson and co¬
workers163 have worked out conditions to release ADP-ribose selectively from all the
known ADP-ribose-amino acid linkages and these are summarised in table 5.1.
The aim of the purification procedure, described in chapter three, was to purify
a "pertussis toxin like" endogenous ADP-ribosyltransferase, ie an enzyme which could
catalyse the transfer of ADP-ribose from NAD+ to cysteine residue of G,. This
hypothesis was tested using erythrocyte ghost membranes. Erythrocyte ghosts are a
well characterised membrane system164 and have been used to study ADP-ribosylation
by bacterial toxins165 and endogenous enzymes76'77. Three quarters of the proteins
present in the erythrocyte membrane comprise of structural proteins eg Spectrin,
tektrin,myosin-like and actin-like polypeptides. Minor constituents which have been
identified include glyceraldehyde-3-phosphate dehydrogenase, protein kinase,
adenylate cyclase and Na+/K+ ATP ase.
The ADP-ribosylation of bovine erythrocyte membrane proteins catalysed by
pertussis toxin, cholera toxin and the purified cysteine dependent NAD'ase were
compared. Labelling ofG proteins was confirmed by recognition of ADP-ribosylated
protein with anti-bodies raised against the C-terminal tails of G; and Gs. Then, ADP-
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Table 5.1 The Stability of the Amino acid -ADP-ribose Linkage
LINKAGE FORMIC SODIUM WEAK HYDROXYL MERCURIC
ACID HYDROXIDE ALKALI AMINE ION
(44%) (1M) (pH 9.0) (pH 7.0) (10 mM)
ARGININE stable released stable released stable
ASPARAGINE stable stable stable stable stable
CYSTEINE stable released stable stable released
DIPHTHAMIDE stable stable stable stable stable
(HISTIDINE)
LYSINE stable released released stable stable
(KETOAMINES)
SERINE OR released stable stable stable stable
THREONINE
ribosylation of a cysteine residue on the target protein was tested in two ways. The
first involved pretreatment of the membrane proteins with N-ethylmaleimide (NEM),
a sulphydryl alkylating reagent which should block the available ADP-ribosylation
sites of the target protein. The second tested the sensitivity of the labelled protein to
mercuric ion. The thio glycosidic bond formed between cysteine and ADP-ribose is
sensitive to nucleophilic attack by the mercuric ion166. It was confirmed that ADP-
ribose was released by separation of the products by ion exchange chromatography.
Finally the sensitivity of the endogenous enzyme to known inhibitors of ADP-
ribosyltransferases and NAD'ases was tested. Thymidine was originally described as
a specific inhibitor of poly(ADP-ribose) polymerase167, however it also inhibits mono-
ADP-ribosyltransferase activity. A concentration of 1 mM causes 60 % inhibion of
NAD+: arginine ADP-ribosyltransferase activity from turkey erythrocytes59. Isoniazid
is a specific inhibitor of NAD'ases and was originally designed as an anti-tuberculosis
drug168. Different vertebrate species have different sensitivities. Sensitive species
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include birds and ruminants, K, about 0.1 mM. Non sensitive species include rodents,
horses and humans. These reagents are commonly used in ADP-ribosylation




5.2.1 ADP-ribosylation of Membrane Proteins
5.2.1.1 Preparation of Bovine Erythrocyte Ghosts
Washed bovine erythrocytes were prepared as described in chapter three,
section 3.2.1. The cells were lysed with hypotonic buffer 10 mM potassium
phosphate, 0.1 mM PMSF, 0.01 % (v/v) 2-mercaptoethanol, 1 mM benzamidine HC1
pH 7.8. The ghosts and unbroken cells were collected by centrifugation (14,000 g,
25 min) and were washed with hypotonic buffer three times until no more
haemoglobin was detectable in the supernatant. The ghost membranes were incubated
with hypotonic buffer containing 0.1 mM EDTA (inverting buffer) for 15 min at
o
30 C to invert them (trapped haemoglobin is visibly released). The amount of protein
present was estimated using the Lowry assay (section 2.5.1) and the membranes were
stored frozen at -70 C.
5.2.1.2 Preparation of Rat Hypothalamus Membranes
The method of Nestler et al.170 was followed. The hypothalamus was
dissected out from the brains of three rats and stored in oxygenated Krebs media, 126
mM NaCl, 5 mM KC1, 4.25 mM NaH2P04, 25 mM NaHC03, 2 mM CaCl2, 2 mM
MgCl2, 10 mM D-glucose pH 7.4. The tisssue was homogenised in ice cold
homogenising buffer, 50 mM Tris HC1, 6 mM MgCl2, 1 mM EDTA, 3 mM
benzamidine, 1 mM DTT, 0.1 mM PMSF pH 8.0 and 5% sucrose. 200 fiL
homogenising buffer per 1 mg weight weight of tissue was used. The membranes
were collected by centrifugation (lQOOCjg, 10 min, 4 °C) and resuspended in the
homogenising buffer. The amount of protein was estimated using the Lowry assay
and the membranes were stored at -70°C until required.
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5.2.1.3 ADP-ribosylation Incubation
The optimised ADP-ribosylation conditions characterised for pertussis toxin by
Ribeiro-Neto et al.171 were followed. A typical ADP-ribosylation reaction contained;
20-40 fig bovine erythrocyte membrane proteins, 5 mM ATP, 0.1 mM GTP,
0.1 mM PMSF, 2 mM EDTA, 50 mM sodium phosphate pH 7.0 and 0-10 /xg
activated pertussis toxin (see section 2.2) or 0 - 200 ng purified cysteine dependent
NAD'ase in a reaction volume 45 /xL. A control assay reaction was performed
containing all of the above ingredients except pertussis toxin or endogenous enzyme.
The reaction was started by the addition of 2 /xM [adenylate-32P]NAD+ (20-30
mCi/mmole) and incubated at 30 °C for 30 min. The reaction was stopped by the
addition of 10% ice cold tri-chloroacetic acid (TCA) and the proteins were allowed
to precipitate on ice for 10 min. The membrane proteins were collected by
centrifugation (13000 g, 5 min) and were washed three times with 0.1% TCA to
remove excess NAD+.
ADP-ribosylation of bovine erythrocyte ghosts by 5 /xg cholera toxin was
achieved using a modification of the above procedure. 10 mM MgCl2 was added to
promote the activation of Gs a, the substrate for cholera toxin. Magnesium is not
included in pertussis toxin incubations because it inhibits ADP-ribosylation of G,
a172-45.
ADP-ribosylation of rat hypothalamus membranes required a further
modification of the assay conditions because the membrane preparation was very
crude. The ADP-ribosylation conditions of Gill and Coburn170, which were designed
to minimise NAD+ depleting reactions, were followed. Typicaly, incubations
contained all of the components described above for the erythrocyte assay plus 10 mM
thymidine, 10 mM isoniazid, 10 mM creatine kinase and 5 units/mL creatine
phosphokinase. Thymidine and isoniazid inhibit poly(ADP-ribose) synthetase and
NAD'ases which will deplete the NAD+ available to the toxin. Creatine phosphate
and creatine phoshokinase are present as an ATP re-generating system.
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5.2.1.4 Detection of ADP-ribosylated Proteins
After precipitation and washing, the membrane proteins were solubilised in
2% (w/v) SDS, 50 mM Tris-HCl pH 6.8 as described in section 2.5.2.2. The
proteins were separated on a 10% SDS polyacrylamide gel and were stained with
Coomassie blue. The gel was dried and then exposed to Hyperfilm-MP (Amersham)
o
using Kodak screen intensifiers for 24-48 h at -70 C. The autoradiograph fdm was
developed using an automatic X-ray fdm developer.
5.2.1.5 Quantification of the Amount of ADP-ribosylated Protein
The amount of label per lane was quantified by scanning the density of the
band using a scanning densitometer (Joyce/loebl). To account for any uneven protein
loading, the density of erythrocyte band V (45 kDa) visualised by coomassie staining
was measured. A relative measure of the amount of labelling was determined from:-
peak area ofADP-ribosylated product
peak area of erythrocyte band V
The peak area was calculated for at least two different time exposures and only
samples from the same gel exposed under identical conditions were compared. It was
therefore not necessary to take the precaution of pre-exposing the film to ensure a
linear response over the time course of the exposure.
5.2.2 Cross Reactivity with G^nd Gs Antibodies
A Western blot analysis of the ADP-ribosylated proteins was performed as
described in section 2.5.3. Erythrocyte ghost proteins separated on 10% SDS
polyacrylamide gel were transferred onto nitro-cellulose (1 A, 2 h). The transfer of
pre-stained markers (Biorad) was used to assess the effeciency of transfer. Excess
binding sites were blocked with 1% dried milk solids, 0.1 % TWEEN in Tris
buffered saline (TBS). Antibodies which had been raised in rabbits, against the C-
terminal decapeptide of Gsa and G,a173 were used in 1/2000 dilution to probe the blot.
Anti-rabbit horseradish peroxidase IgG conjugate was used as the second antibody in
a 1/4000 dilution. The anti-body labelling was detected by ECL.
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5.2.3 Identification of the Amino Acid Linkage
5.2.3.1 NEM Treatment of Membranes
N-ethyl-maleimide (NEM) is a powerful sulphydryl alkylating reagent and will
readily react with reactive thiol groups on proteins to form an acid resistant adduct.
It is important, first, to remove any free thiol present in the preparation, and second,
to use fresh NEM. NEM is hydrolysed at pH 7.0 and above to form inactive N-
ethylmaleamate.
Prepared bovine erythrocyte membranes were washed three times with 50 mM
phosphate buffer pH 7.2, 0.1 mM PMSF, 0.1 mM EDTA to remove excess 2-
mercaptoethanol. 1 mM NEM (freshly prepared) was then added to the membranes
and incubated at 30 °C, for 30 min. NEM was removed by washing the membranes
three times with inverting buffer. A control membrane preparation was treated as
above, except NEM was not added. ADP-ribosylation of these treated membranes
was performed as described in section 5.2.1.3.
5.2.3.2 Release of Label
The sensitivity of the ADP-ribosyl-protein linkage to cleavage by neutral
hydroxylamine or mercuric ion was tested. After precipitation and washing of the
membrane proteins the sample was divided into three equal portions. One was treated
with 0.5 M neutral hydroxylamine, 0.5 M NaCl pH 7.4 at 30°C for a maximum of
3 h. Another was treated with 10 mM mercuric acetate, pH 3.0 at 30 C for a
maximum of 30 min. The last was set up as a control incubation. The sample was
incubated in 50 mM potassium phosphate buffer, 0.5 M NaCl, pH 7.4 for a maximum
of 3 h. The precipitate was not solubilised under these conditions, but remained as
a fine white precipitate in suspension. The precipitate was collected by centrifugation
(13,000 g, 5 min) and the proteins were then solubilised and separated out on 10%
SDS polyacrylamide gels as described in section 5.2.1.4. Pertussis toxin catalysed
ADP-ribosylation of rat hypothalamus membranes were used as a standard for ADP-
ribose-cysteine-protein.
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5.2.3.3 Detection of Released Label
To detect the type of label released by mercuric acetate it was necessary to
remove excess NAD+ efficiently. This was achieved by first separating the products
on 10% SDS polacrylamide gels, and then electro-eluting the labelled protein (3 W,
constant power, 3 h) as described in section 2.5.4. The eluted protein was then treated
with 10 mM mercuric acetate, at 30°C, for 30 min. The protein was precipitated by
adding 5% (v/v) perchloric acid. The supernatant was neutralised by addition of
potassium hydroxide (4°C) and the insoluble salt (potassium perchloride) formed was
removed by centrifugation (13,000 g, 5 min). The sample was diluted two fold with
100 mM potassium phosphate pH 4.5 before applying to a Spherisorb S5-SAX HPLC
column (see section 2.4.2), which had been equilibrated in 100 mM potassium
phosphate buffer pH 4.5. The products were separated on the column by isocratic
elution. 0.25 mL fractions were collected and 4 mL scintillant (Pharmacia, HiSafe)




5.3.1 ADP-Ribosylation of Erythrocyte Ghost Membrane Proteins
The labelling observed in erythrocyte ghost membranes after incubation with
|32P-adenylate|NAD+ and pertussis toxin, cholera toxin, purified cysteine dependent
NAD'ase or membranes only are shown in Figure 5.1. The membrane proteins were
separated out on a 10% SDS polyacrylamide gel and lane (a) shows the proteins
visible after staining with Coomassie blue. The major polypeptides of the red blood
cell membrane identified by Steck165 are indicated. After exposure of the separated
proteins to autordiography film for 48 h, several radiolabeled bands were detectible
(lanes (b) to (e)). The molecular weight of these labelled polypeptides was estimated
by comparison with the relative mobility of known molecular weight standards, as
indicated. Free [32P]NAD+ ran with the dye front during electrophoresis and was
washed out of the gel during the protein staining procedure, such that only low levels
of radioactivity was detected in the dye front. Some of this activity may have been
due to radiolabeled low molecular weight proteolytic fragments.
The major radiolabeled product observed was a 55 kDa band. The labelling
in this region decreased in the presence of cholera toxin but was increased relative to
the control in incubations containing cysteine dependent NAD'ase and pertussis toxin.
This band is not coincident with any of the major polypeptides visible with Coomassie
staining, suggesting that a minor component of the erythrocyte membrane has been
labelled. The pattern of radiolabelled products for incubations containing pertussis
toxin and cysteine dependent NAD'ase were similar; two bands of high molecular
weight at the top of the gel, a 60 kDa band, enhanced labelling of a 55 kDa band and
very faint labelling of a 29 kDa protein. However, only incubations with pertussis
toxin showed labelling of a 41 kDa band. Cholera toxin produced unique labelling
of a 66, 50, 45 and 42 kDa polypeptides. The appearance of the high molecular
weight doublet, 66 kDa band and 29 kDa band were variable between membrane
preparations, whereas the labelling of the 55 kDa protein was consistent.
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Figure 5.1 ADP-ribosylation of Erythrocyte Ghost Membranes
Lane (a) Coomassie staining of erythrocyte ghost proteins with the major erythrocyte
ghost proteins I - VII indicated. The autoradiograph of ADP-ribosylated ghost
proteins after incubating the membranes with [32P]NAD+ and membranes only (b),
cysteine dependent NAD'ase (c), pertussis toxin (d) and cholera toxin (e) are shown.
5.3.1.1 Dose Response
The effect of adding increasing amounts of cysteine dependent NAD'ase or
pertussis toxin to the ADP-ribosylation assay was investigated. Figure 5.2 shows the
autoradiographs of the 50-60 kDa region for incubations carried out for 15, 30 and
60 min, containing 0 - 200 ng of purified cysteine dependent NAD'ase. The density
of labelling was quantified (as described in section 5.2.1.5) and are shown in the
graph. Each incubation contained 15 fig of membrane proteins and the separated
proteins were exposed to the autoradiograph film for 36 hours. Very low levels of
labelling was observed after 15 min. After 60 min incubations a dose response on
additionof cysteine dependent NAD'ase was difficult to detect because background
labelling was also high and amount of target protein becomes limiting. A dose
response was observed, following a 30 min incubation, most clearly. A maximum
three fold increase in the amount of labelling of the 55 kDa protein was observed on
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Figure 5.2 Labelling of Erythrocyte Ghost Membrane Proteins: Dose response
for the Cysteine Dependent NAD'ase. 15/xg of erythrocyte ghost membranes were
incubated with 0-200 ng cysteine dependent NAD'ase and 2.5 /xM [32P]NAD+ for 15
(O), 30 (•), and 60 minutes (■) at 30°C. The 15 minute incubation was repeated
with 25 /zM |32P|NAD+ (□).
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addition of 100 ng of cysteine dependent NAD'ase. Further additions of NAD'ase
did not increase the amount of labelling; in fact a reduction was observed.
Long incubation times and high concentrations of cysteine dependent NAD'ase
in the assay do not produce high levels of labelling. This may be explained by the
fact that the NAD'ase activity of the enzyme hydrolyses all the available NAD+
during the time course of the assay or only a limited amount of target protein is
available for modification. To test whether the maximal labelling observed was due
to substrate depletion duplicate assays were set up. One contained 2.5 /zM NAD+ and
the other 25 jzM NAD+ (specific activity of both was 20 mCi/mmole). The cysteine
dependent NAD'ase dose response was repeated at both concentrations. No further
increase in labelling in the presence of a high concentration of NAD+ was observed,
suggesting that NAD+ was not a limiting factor for the enzymatic reaction.
Treatment Salt pH 11
NAD'ase + - +
Figure 5.3 ADP-Ribosylation of Salt Washed Erythrocyte Membranes. The 80-
35 kDa region of the autoradiograph is shown.
Unexpectedly high levels of endogenous ADP-ribosyltransferase activity, in the
incubations containing erythrocyte ghost membranes only, was observed. To
determine whether this activity was membrane associated or due to contamination by
cytosolic proteins, the membranes were washed using more stringent conditions. The
ghost membranes were treated with 50 mM potassium phosphate, 200 mM NaCl
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pH 7.2 or 0.1 M potassium carbonate buffer pH 11.0. Under these washing
conditions only integral membrane proteins should remain; cytosolic and loosely
associated membrane proteins should be stripped away. The ADP-ribosylation
experiments were repeated after these washing procedures and labelling of a 55 kDa
protein was observed again in the presence or absence of added ADP-
ribosyltransferase (Figure 5.3). The washing procedures reduced the level of the
background labelling, but did not inhibit it completely, suggesting that the background
activity must be membrane associated. ADP-ribosylation of the 60 kDa band was no
longer observed after these more stringent washing conditions. This suggests that the
60 kDa protein was loosely associated with the membrane, whereas the 55 kDa
protein must be an integral membrane protein which was not removed by washing
with salt or high pH.
Pertussis Toxin (fig)





Figure 5.4 Labelling of Erythrocyte Ghost Membrane Proteins: Dose
Response of Pertussis Toxin
Figure 5.4 shows the labelling observed after incubating erythrocyte ghost
membranes with pertussis toxin (0 - 10 fig) and [32P|NAD+ for 30 min. Addition of
5 fig of activated pertussis toxin increased the amount of labelling of the 55 kDa band
twofold. Labelling of 41 kDa and 27 kDa was maximal for 5 fig. Further additions
of toxin lead to a reduction in the amount of labelled protein observed. The NAD'ase
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activity of the pertussis toxin may become significant at high concentrations of toxin
in the assay. The toxin may have hydrolysed the NAD+ substrate before significant
levels of target proteins were modified.
5.3.1.2 Reaction of Free ADP-ribose with Membrane Proteins
The possibility that the labelling of erythrocyte membrane proteins observed
was due to the non-enzymatic reaction of susceptible groups on the protein with ADP-
ribose was investigated. The incubation conditions used were a modification of those
of Ribeiro-Neto et al.171 in which inhibitors of NAD'ase and poly(ADP-ribose) were
not included. Erythrocytes ghosts have been reported to be good systems for ADP-
ribosylation as they have low levels of NAD+ depleting reactions. Erythrocyte
membranes are known to have a NAD'ase on the outer surface of the cell174. In the
ADP-ribosylation assay inverted re-sealed ghosts were prepared such that the
membrane associated NAD'ase activity should be shielded from the reactants.
However carryover of low levels of NAD'ase could generate a significant amount of
ADP-ribose, which may modify proteins directly and account for the background
labelling observed. The increased levels of labelling observed on addition of the
cysteine dependent NAD'ase or pertussis toxin may result from the increased
production of ADP-ribose.
The NAD'ase activity of the cysteine dependent NAD'ase used in the assay
was determined. A rate of 5 pmol min1 in the presence of 10 fiM NAD+ and 10 mM
cysteine was found. If this rate were to occur during the ADP-ribosylation reaction
then 68% of the total NAD+ would be used up. However, the ADP-ribosylation
conditions are such that NAD+ and reducing reagent are present at sub-saturating
levels, so cysteine dependent NAD'ase activity will be minimised.
Free [adenylate-32P]ADP-ribose was prepared from [32P-adenylate]NAD+.
10 fiM [32P]NAD+ (20 mCi/mmole) was incubated with 10 /*g pig brain NAD'ase
(15 nmol.min mg ') (Sigma, E.C. 3.2.2.5.) in 50 mM potassium phosphate buffer,
pH 7.2 at 30°C for 30 min. The protein was removed by filtration through a
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Figure 5.5 Modification of Erythrocyte Membrane Proteins by free ADP-
ribose. Control incubations containing 1/xM [32P]NAD+ and 5 /xg of activated
pertussis toxin (A), 100 ng cysteine dependent NAD'ase (B) or membranes only (C).
membrane, which had a Mr cut-off of 10,000. The filtrate was applied to S5-SAX
column and ADP-ribose was separated from NAD+ as described in materials and
methods section 2.4.2. ADP-ribosylation reactions were set up containing 40 /xg
membrane proteins and a range of ADP-ribose concentrations (0 - 0.4/xM) equivalent
to a maximum of 45% NAD+ hydrolysed. Control incubations containing 1 /xM
NAD+ with and without cysteine dependent NAD'ase or pertussis toxin were set up.
Figure 5.5 conclusively shows that the ADP-ribosylated 55 kDa band observed in
control and experimental samples is not due to reaction of free ADP-ribose liberated
during the time course with susceptible groups on the membrane protein.
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5.3.2 Cross Reactivity Gs and Gs Antibodies
The ADP-ribosylation of a 55 kDa protein by the purified enzyme and
pertussis toxin was observed. This is too high a molecular weight for G (39 -
42 kDa), although it is within the range for Gs (42 - 55 kDa). However, it is not
uncommon for proteins to run anomalously on SDS polyacrylamide gel
electrophoresis. The acid precipitation and prolonged solubilisation in 0.1 % SDS
buffer at 80 C may have caused cross linking of proteins to occur or the ADP-
ribosylation modification itself may have altered the mobility of the protein. To test
these possibilities and to confirm endogenous ADP-ribosylation ofG protein the cross
reactivity of the labelled protein with G, and Gs antibodies was investigated.
(a) (b) (c) (d) (e) Da
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Figure 5.6 Recognition of erythrocyte Membrane Proteins by anti G; and anti
Gs antibodies.
Lane (a) shows the autoradiograph of erythrocyte ghost proteins labelled by the
cysteine dependent NAD'ase. Western blots of untreated and ADP-ribosylated
membranes probed with anti-peptide antibodies raised against Git* are shown in lanes
(b) and (c), respectively. Lanes (d) and (e) show the Western blots of untreated and
ADP-ribosylated membranes probed with anti-Gsa anti-peptide antibody. The
antibodies were detected using ECL.
A Western blot analysis of ADP-ribosylated erythrocyte ghost proteins and
corresponding autoradiograph are shown in Figure 5.6. A maximum of 10 min
exposure time was required for detection of the antibody labelling. Exposure of the
radiolabeled protein to film for this time did not produce any detectible bands. After
five hours the ECL reagent was used up and further exposure of the blot (in the
absence of radiolabel) did not produce any detectible bands on the film. The blot was
then exposed to Hyperfilm MP for 24 h to detect the radiolabeled protein.
Experiments were repeated in which the radiolabeled proteins were detected before
treatment with the anti-bodies. No difference in the pattern of ADP-ribosylated
protein or antibody labelling was observed. All the bands observed result from
interaction of the second antibody (anti-rabbit-HRP conjugate) with the anti-peptide
antibody. Incubation of the membranes with second antibody only, or ECL reagents
only, did not produce any detectible bands.
The reaction of anti G, and anti Gs a antibodies with treated and untreated
membranes are shown in Figure 5.6. The relative intensities of the bands recognised
by the antibodies were unchanged and no shift in the bands recognised by the
antibodies was observed between the labelled and unlabelled proteins. These data
suggest that the ADP-ribosylation conditions do not inhibit the recognition of Gj and
Gs by the anti- peptide antibody and do not cause a shift in the mobility of G, and Gs
on SDS-PAGE. Overlay of the blot and autoradiograph images showed that the
55 kDa ADP-ribosylated band was not recognised by the C-terminal anti-peptide
antibodies of G^ or Gsor. This is seen more clearly by examination of the scanning
densitometry data shown in Figure 5.7. G,a anti-peptide antibody recognises 41 kDa
(faint labelling), 71 kDa and 64.5 kDa (heavy labelling) proteins. Gsa anti-peptide
antibody recognises a 48 kDa and 64,500 kDa protein. The antibodies are known to
cross react with BSA and this may account for the labelling observed at 64 - 71 kDa.
The radiolabeled band is broad and partially overlaps with the 65 KDa band
recognised by both antibodies. However, the most intensely radiolabeled portion of
the band is not recognised by either antibody, suggesting that modification of a novel
acceptor protein has occurred.
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Figure 5.7 Comparison of the Autoradiograph (shaded area) and Western Blot
of ADP-ribosylated Erythrocyte Ghost Proteins by Scanning Densitometry.
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5.3.3 Identification of the type of ADP-Ribosyl Amino Acid Linkage
5.3.3.1 Sensitivity of ADP-ribosylation Observed to Pre-Treatment with NEM
NEM + - +
NAD'ase + +
Figure 5.8 ADP-ribosylation of Erythrocyte Membranes after Pre-Treatment
with NEM
Free thiol groups associated with the erythrocyte membrane proteins were
alkylated using NEM. The ability of the cysteine dependent NAD'ase to ADP-
ribosylate these modified proteins is shown in Figure 5.8. The background membrane
associated ADP-ribosylation was not effected, whereas the enhanced labelling of the
55 kDa protein by the cysteine dependent NAD'ase was inhibited by NEM treatment
of the membranes. This result is consistent for a modification of a cysteine residue
on the 55 kDa protein and suggests that the background labelling may result from the
labelling of a different residue, which is insensitive to treatment with NEM, on the
same protein or a different protein with a similar molecular weight.
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5.3.3.2 The Sensitivity of ADP-Ribosyl-Protein to Neutral Hydroxylamine and
Mercuric Acetate
Neutral Hydroxylamine Mercuric acetate
0 1 2 3 hours 0 10 20 30 minutes
•
Figure 5.9 The Sensitivity of ADP-Ribosyl-G; to Hydroxylamine and Mercuric
Ion
The conditions required to cleave ADP-ribosyl-cysteine were tested using
ADP-ribosylated G, prepared from hypothalamus membranes incubated with pertussis
toxin. Hypothalamus membranes were chosen because they were a better source of
pertussis toxin substrate and background membrane associated activity was very low.
Approximately 100 fold more G protein was detected with G,a anti-peptide antibody
in the hypothalamus membranes compared to the erythrocyte membranes. Figure 5.9
shows the time dependent release of radiolabel in the presence of 10 mM mercuric
acetate or 0.5 M hydroxylamine pH 7.4, 0.5 M NaCl. The release of [32P]ADP-
ribose was rapid in the presence of mercuric ion; no label was detectible after 10
mins, at 30°C. No label release was detected with neutral hydroxylamine, even after
three hours, thus confirming the stability of the ADP-ribosyl linkage to this
nucleophile.
Erythrocyte ghost membranes that had been ADP-ribosylated by endogenous
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Figure 5.10 The Sensitivity of Radiolabeled Erythrocyte Membrane Proteins
to Neutral Hydroxylamine and Mercuric Acetate
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the conditions determined for pertussis toxin labelled G,. The results are shown in
Figure 5.10. The amount of label per band was quantified by scanning the intensity
of the band using a scanning densitometer and are shown in the graph. Background
labelling was apparently stable to both neutral hydroxyl amine and mercury acetate.
The increased labelling observed of the 55 kDa protein by cysteine dependent
NAD'ase and pertussis toxin was released by mercury acetate, but was stable to
hydroxylamine. Pertussis toxin catalysed labelling of a 41 kDa protein was released
completely by treatment with mercury acetate.
5.3.3.3 Detection of the Released Label
To confirm that ADP-ribose and not NAD+ or some other [32P-adenylate]-
containing compound was released by mercuric ion the products of the reaction were
separated on S5-SAX ion exchange column. The sample was treated as describred in
section 5.2.3.3. The elution times of NAD+ and ADP-ribose that had been treated
with mercuric acetate under the conditions of the experiment and untreated fresh
NAD+ and ADP-ribose were compared. The effect of mercuric acetate on NAD+
during the time course of the reaction was tested to ensure that break down did not
occur or the elution time change.
The standards are shown in Figure 5.11 and are detected at 254 nm. Mercuric
acetate does not promote the breakdown of NAD+, and did not effect the elution time
of 4.4 min. The elution time of ADP-ribose was effected by the presence of mercuric
acetate, changeing from 17 min to 13 min. This change in elution time may be
explained by a small change in the pH caused by the treatment with mercury acetate
on application of the sample to the column. To account for changes in elution time
between samples the position of radiolabeled product detected by scintillation
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Figure 5.12 Detection of ,2P in the Eluate from SAX-HPLC. Incubations were
performed containing membranes only (♦), pertussis toxin (□), or cysteine dependent
NAD'ase (■).
The radiolabel detected in the column eluate for enzymatic and non-enzymatic
ADP-ribosylation incubations are shown in Figure 5.12. Radiolabel was detected in
fractions which were coincident with both NAD+ and ADP-ribose. Incubations
containing pertussis toxin and cysteine dependent NAD'ase showed proportionately
more ADP-ribose than incubations containing membranes only. The ratio of counts
associated with NAD+ and counts associated with ADP-ribose for pertussis toxin and
cysteine dependent NAD'ase containing assays were similar, 0.9 and 2 respectively.
Membrane only incubations resulted in five fold less ADP-ribose released relative to
NAD+ (ratio NAD+: ADP-ribose =10).
Although the protein precipitate had been washed three times with 0.1 % TCA
to remove excess NAD+ the possibility that some NAD+ remained trapped within the
precipitate cannot be ruled out. To overcome this problem the radiolabelled proteins
were separated on a 10% SDS polyacrylamide gel. Only covalently bound radiolabel
130
will remain with the protein and free NAD+ and ADP-ribose will run with the dye
front. The radiolabeled protein was excised from the gel and the protein electro-
eluted as described in section 2.5.4.
The electro-elution conditions used eluted more than 95% of the ADP-
ribosylated 55 kDa protein from the gel. No counts were detectible in the gel after
elution; 1100 cpm were eluted from the incubations containing membranes only and
1800 cpm from incubations containing cysteine dependent NAD'ase. The electro-
eluted protein was treated with mercuric acetate and the protein removed by
precipitation with 10% perchloric acid as described in section 5.2.3.3. 100 /aM NAD+
and ADP-ribose standards were added to the sample before application to the column
to act as internal controls to indicate any discrepancies in the elution times between
runs. The graph in Figure 5.13 shows the counts detected per 0.25 mL fraction
collected and the elution times of NAD+ and ADP-ribose standards detected at 254


















Figure 5.13 Release of Radio-label by Mercuric Acetate Treatment of Electro-
eluted 55 kDa Protein which had been labelled in the presence (O) and absence (■)
of cysteine dependent NAD'ase.
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collected and the elution times of NAD+ and ADP-rihose standards detected at 254
nm are indicated. Release of 3H label by treatment with mercuric acetate was only
detected for samples which had been incubated with the cysteine dependent NAD'ase.
No 3H counts were released from samples incubated with membranes only. The
counts released were low and were equivalent to 5% of the total label incorporated
into the 55 kDa band. The electro-elution buffer contained 1 % SDS and this may
have inhibited the reaction of the mercuric ion with the ADP-ribose-protein substrate.
The released 3H counts were clearly coincident with ADP-ribose. These results
suggest that a mono-ADP-ribosyl-cysteine on the 55 kDa had been formed and rule
out the possibility of the labelling being due to covalent modification of the protein
by NAD+.
5.3.4 Thymidine and Isoniazid Inhibition
The inhibitory properties of these two commonly used inhibitors of NAD+
depleting reactions in ADP-ribosyltransferase incubations were tested. Incubations
containing inhibitor with and without cysteine dependent NAD'ase were set up.
Figure 5.14 shows the autoradiograph of the 55 kDa region and a graph of the relative
peak intensity of each lane determined by scanning densitometry. The amount of
labelling observed in the presence or absence of the cysteine dependent NAD'ase was
compared to the labelling observed from incubations containing membranes only. In
the absence of isoniazid and thymidine, a 50% increase in the amount of label
incorporated into the 55 kDa band was observed in incubations which contained
cysteine dependent NAD'ase. Isoniazid inhibited both the background and cysteine
dependent NAD'ase catalysed labelling, such that no significant difference in the
amount of labelling between the control and the experiment could be measured.
Thymidine inhibited both background and cysteine dependent NAD'ase catalysed
ADP-ribosylation. 50% inhibition was observed compared to untreated membranes
and no significant difference between control and experiment could be detected.
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Figure 5.14 The Effect of Inhibitors on the Extent of ADP-Ribosylation
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5.3.4.1 Inhibition of NAD glycohydrolase
The inhibition properties of these compounds were investigated further using
the NAD glycohydrolase assay as a model system. The NAD'ase assay was
performed at saturating (100 fiM) and sub-saturating (33 and 10 fiM) concentrations
of NAD+, 50 mM potassium phosphate, 100 mM cysteine pH 7.4. 0-10 mM
concentrations of inhibitor was added to the assay. The rate of nicotinamide released
was calculated and the concentration at which half maximal activity was observed was
estimated. More detailed inhibitor kinetic studies were not carried out because there
was not enough active enzyme available.
The inhibition curves for isoniazid and thymidine are shown in Figure 5.15
and Figure 5.16. Isoniazid and thymidine inhibited the cysteine dependent NAD'ase
assay, and 50% inhibition was observed at 0.9mM and 1.2 mM, respectively, at
saturating concentrations of NAD+. The concentration of isoniazid required to give
50% inhibition was dependent on the concentration of NAD+ in the assay; 50%
inhibition was observed at 0.8 mM in the presence of 33 fiM and 0.6 mM in the
presence of 10 fiM NAD+. These data suggest that isoniazid was a competitive
inhibitor against NAD+ of the cysteine dependent NAD'ase activity. The inhibition
observed in the presence of thymidine was independent of the concentration of NAD+
in the assay; 50% inhibition was observed at 1.2 mM at saturating and sub-saturating
concentrations of NAD+. These data suggest that the inhibition of the cysteine
dependent NAD'ase by thymidine was non-competitive with respect to NAD+.
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isoniazid (mM)
Figure 5.15 Isoniazid inhibition of NAD glycohdrolase activity. Inhibition curves
at 100 pM NAD+(D), 33 pM NAD+(B) and 10 pM NAD+(Q) are shown.
thymidine (mM)
Figure 5.16 Thymidine inhibition of NAD glycohdrolase activity. Inhibition
curves at 100 pM NAD+(D), 33 pM NAD+(B) and 10 pM NAD+(0) are shown.
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5.4 Discussion
5.4.1 ADP-Ribosylation of Bovine Erythrocyte Ghosts
In this chapter evidence was presented that the cysteine dependent NAD'ase
purified from bovine erythrocytes can catalyse the transfer of ADP-ribose from NAD+
to a target protein found in the bovine erythrocyte. Incubation of bovine erythrocyte
ghosts with |32P|NAD+ lead to the labelling of a 55-60 kDa region of the gel. This
labelling was enhanced by the addition of cysteine dependent NAD'ase: A maximum
150% increase in intensity was observed. The purified cysteine dependent NAD'ase
used in these assays appeared as a single band on silver stained SDS polyacrylamide
gels. It seems likely that the ADP-ribosyltransferase activity observed is due to this
protein and not some contaminant. There was a linear response between the amount
of cysteine dependent NAD'ase added and the amount of radiolabeled product
observed and later experiments showed that the background and enzyme labelled
protein had different sensitivities to treatment with mercuric acetate. However, the
possibility remains that addition of the purified cysteine dependent NAD'ase adds
some factor which promotes ADP-ribosylation of the 55-60 kDa protein, in a similar
fashion to ADP-ribosylation of Gs by cholera toxin which requires some mammalian
cytosolic protein factor termed ADP-ribosylation factor (ARF)175.
Surprisingly, incubations containing pertussis toxin also showed increased
labelling in this 55-60 kDa band as well as the expected 42 kDa protein. Cholera
toxin, on the other hand reduced labelling in this region. The possibility that the
apparent 55-60 kDa protein was G, or Gs was ruled out by testing the cross reactivity
of the radiolabeled band with anti-bodies raised against the C-terminal tails of Gs and
Gs. The labelling of proteins catalysed by the cysteine dependent NAD'ase were not
coincident with bands identified by anti-Go; or anti-Gso; antibodies. The anti peptide
antibodies were raised in rabbits using BSA as a carrier. The polyclonal antibodies
recognised 64.5 kDa protein present in the assay more strongly than G, or Gs. This
protein is most likely BSA contamination from the preparation of bovine erythrocyte
ghosts.
Gill and Wookalis176 reported ADP-ribosylation of the major erythrocyte
protein band III (88 kDa) by cholera toxin. ADP-ribosylation of this region was not
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observed but the 76 kDa labelling is coincident with band IV (72 -78 kDa). This
protein is present at relatively high concentration and therefore the labelling observed
is not very specific. There are a few reports in the literature of pertussis toxin
modifying protein other than than members of the trimeric G proteins; auto-ADP-
ribosylation177, tubulin178 and most recently a 66 kDa protein in basolateral
membranes179. ADP-ribosylation of a 28 kDa protein is seen under certain assay
conditions and has been attributed to auto-ADP-ribosylation of the SI subunit.
Tubulin is a 120 kDa, made up of two subunits, a and 13 of 60 kDa each. It forms
part of the cytoskeleton and contains tightly bound GDP, however ADP-ribosylation
of tubulin by pertussis toxin has not been shown to be physiologically relevant. These
few reports suggest that ADP-ribosylation of proteins by pertussis toxin may not be
as specific for the trimeric G proteins G,, G0 and transducin as once thought.
5.4.2 Evidence for ADP-Ribosyl-Cysteine-Protein
The labelling observed could have been due to non-specific modification of
susceptible residues on the target protein. Specific non-enzymatic labelling of proteins
has been seen in several systems, eg ADP-ribosylation of 50-55 kDa proteins in rat
liver mitochondria96 and 36 and 39 kDa cytosolic proteins of skeletal muscle180. The
possibility that addition of cysteine dependent NAD'ase or pertussis toxin simply
increased the amount of ADP-ribose generated which then reacted with susceptible
residues on the target protein was ruled out. The concentration of NAD+ in the ADP-
ribosyltransfer reaction was 2.5 /iM which is sub-saturating for the cysteine dependent
NAD'ase and pertussis toxin, thus NAD glycohydrolase activity would have been
extremely slow. Production of ADP-ribose during the time course of the reaction
would have been barely significant and incubation of the erythrocyte ghost membranes
with free ADP-ribose did not cause any labelling of any protein. The possibility that
the labelling observed was due to direct modification by NAD+ remained.
Evidence that the enhanced labelling of the 55-60 kDa protein produced by the
addition of cysteine dependent NAD'ase or pertussis toxin was ADP-ribosylation via
a cysteine residue came from two experiments. The first showed that the labelling
was sensitive to pre-treatment of the membrane proteins with NEM. This suggested
that the target protein contained a reactive thiol which was susceptible to alkylation
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by NEM and which was then no longer available as a site for ADP-ribosylation. This
treatment also reduced the background labelling of this protein, suggesting that either
the membrane preparation contained some of the purified protein whose site of action
became blocked, or the membrane associated enzymes were themselves modified by
NEM and were inactivated. The second experiment showed that the enzymatic
labelling was released by treatment with mercuric acetate. The amount of labelling
remaining after treatment of the ADP-ribosylated protein with mercuric acetate or
hydroxylamine was analysed by separation of the proteins on SDS polyacrylamide gels
and autoradiography. The results suggested that the background labelling was
insensitive to both treatments while the enhanced labelling was sensitive to mercuric
ion. The ADP-ribosylation observed may be due to labelling of different proteins of
similar molecular weight or modification of the same protein, but at different sites.
Transducin is an example of a protein which has more than one site for ADP-
ribosylation9. Transducin is a peripheral membrane protein of rod outer segment of
the eye and is the only member of the G protein family which can be modified by
both pertussis toxin and cholera toxin.
The high background labelling observed may be due to non-specific binding
of NAD+. Mc Donald and Moss115 have described a covalent modification of
glyceraldehyde-3-phosphate dehydrogenase which was first thought to be ADP-
ribosylation114, but was actually covalent binding of NAD+ at the active site. The
preparation of ADP-ribosylated protein involved the precipitation of proteins with 5 %
TCA and washing of the pellet with 0.1% TCA. The background labelling is thus
stable to acid, hydroxylamine and mercuric acetate. These findings rule out the
possibility of modification through serine, threonine, arginine or cysteine residues.
Labelling of lysine residues which are abundant on the surfaces of proteins is a
possibility, which has not been tested. Modification of this groups may be
distinguished by its sensitivity to treatment with weak alkali (pH 9.0). ADP-
ribosylation of a modified histidine residue (diphthamide), cf diphtheria toxin or an
asparagine residue, cf botulinum C3 toxin cannot be ruled out. These ADP-ribosyl
linkages are stable to all the chemical treatments described and, as yet, no protocol
has been determined to identify these linkages by selective chemical release.
Both NAD+ and ADP-ribose were detected by separation on HPLC after
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treatment with mercuric acetate. The NAD+ present may have been covalently
attached to the protein via a thioester linkage which was susceptible to attack by the
mercuric ion. However, in these experiments the complete removal of un-reacted
NAD+ cannot be ruled out. Repeating the experiment after electroelution of the
labelled product from the gel showed that only ADP-ribose was released by treatment
with mercuric ion. The amount of released product was very low, and accounted for
5% of the total counts incorporated in the eluted material. The presence of SDS
bound to the protein may have blocked the reaction of the mercuric ion with the
thioglycosidic bond either physically, by reducing the accessibility of the ADP-ribosyl
linkage to the reagent, or chemically, by reacting with the mercuric ion. Better label
release may be obtained by increasing the concentration of mercuric acetate ten fold
or increasing the time and the temperature of the reaction.
5.4.3 Inhibitors of ADP-ribosylation
Finally the effect of known inhibitors was tested. Half maximal inhibition of
the cysteine dependent NAD'ase activity was observed at a concentration of 1.2 mM
thymidine. This value is similar to that quoted for poly(ADP-ribose) polymerases and
NAD+: arginine ADP-ribosyltransferases (1 mM). However the specific inhibition
of poly (ADP-ribose) polymerase is thought to arise from competitive inhibition of
thymidine at the active site. In this case, a decrease in the concentration required to
give 50% inhibition at sub-saturating substrate conditions compared to saturating
conditions would be expected. This was not seen. The inhibition observed was
independent of the concentration of NAD+ in the assay, and was indicative of non¬
competitive inhibition, ie the inhibition was independent of whether the substrate was
bound or not. The inhibition of the NAD glycohydrolase activity corresponded with
potent inhibition of the ADP-ribosylation of 55-60 kDa protein observed. Thymidine
inhibited background labelling to 30% of normal, and the addition of cysteine
dependent NAD'ase did not produce any increase in the labelling.
Competitive inhibition was suggested by the inhibition shown by isoniazid.
The concentration of inhibitor required to give 50% inhibition decreased as the
concentration of NAD+ decreased in the assay, suggesting that both molecules were
competing for the same site on the enzyme. Again, inhibition of the NAD
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glycohydrolase activity and inhibition of the ADP-ribosyltransferase activity was
observed. Inhibition of background and enzymatic activity was observed although this
was not as dramatic as the effect of thymidine. ADP-ribosylation of 60% of the
protein observed in the absence of inhibitor was seen. This may seem surprising since
a low concentration of NAD+ (2.5 fiM) and a high concentration of isoniazid
(10 mM) were employed in the assay. If isoniazid was a competitive inhibitor of the
cysteine dependent NAD'ase, then it would be expected that the enzyme activity
would be completely inhibited at these concentrations of substrate and inhibitor.
Isoniazid is an analogue of nicotinamide - isonicotinic acid hydrazide.
Experiments to identify product inhibition properties of nicotinamide showed that no
inhibiton was obtained even at 100 fold molar excess of nicotinamide compared to
substrate. Are these findings anomalous? Nakazawa et al.m proposed that isoniazid
underwent a transglycosidation reaction with NAD+. This may be catalysed
ISONIAZID ISONICOTINIC ACID HYDAZIDE NICOTINAMIDE
ADENINE DINUCLEOTIDE
Nakazawa's Proposed Mechanism of Inhibition by Isoniazid
enzymatically with isoniazid acting as an acceptor for ADP-ribose, or ADP-ribose
liberated by NAD'ase action may react directly with isoniazid in solution. The
product isonicotinic acid hydrazide adenine-dinucleotide is a mimic for NAD+ and
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competes at the active site for binding. The different sensitivities of NAD'ases seen
between species may be attributed to their ability to hydrolyse this modified NAD+.
The non-sensitive NAD'ases of horse and human can hydrolyse the modified NAD+
whereas the sensitive NAD'ases of rodents and ruminants cannot and are inhibited
by isoniazid (Kt 0.1 mM). This mechanism of action may be used to explain the
apparent anomolies. In the ADP-ribosylation assay ADP-ribose will be transferred
to the target protein in preference to isoniazid. Very little free ADP-ribose will be
generated such that only low levels of inhibitor can form and thus lower than expected
inhibition is observed in the ADP-ribosylation assay than expected from the NAD
glycohydrolase.
The sensitivity of the cysteine dependent NAD'ase to isoniazid and thymidine
is an important difference between it and pertussis toxin, which is insensitive. This
property is in common with other endogenous ADP-ribosyltransferases and maybe
indicates important mechanistic differences between the bacterial and mammalian
enzymes. This inhibition limits the application of the purified enzyme. Potential
substrates, which are present in membrane preparations containing high levels of
intrinsic NAD+ depleting enzymes may not be identified. Addition of thymidine or
isoniazid will inhibit the cysteine dependent NAD'ase, and without their addition
NAD+ will not be available to the enzyme. This may have been the case for the rat
hypothalamus membranes to which 10 mM isoniazid and 10 mM thymidine were
added. High levels of ADP-ribosylation of G0 was observed with pertussis toxin but
very little ADP-ribosylation activity was observed in the absence of pertussis toxin or
the presence of cysteine dependent NAD'ase.
Chapter six
CONCLUSION AND FUTURE WORK
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6.1 Conclusions
An endogenous cysteine specific ADP-ribosyltransferase was isolated from
bovine erythrocytes by making assumptions about some of the expected properties of
this enzyme by comparison with the known properties of pertussis toxin. The strategy
used to purify the enzyme was based on the assumption that like pertussis toxin the
enzyme would be able to use free cysteine as an acceptor for ADP-ribose. This
activity could be identified as a cysteine dependent NAD'ase activity in fresh bovine
erythrocyte lysate. The NAD glycohydrolase assay enabled the screening of the large
number of fractions during the purification protocol and assessment of the
effectiveness of the purification procedure.
In chapter three the development of a three step purification procedure to
isolate this cysteine dependent NAD'ase from bovine erythrocytes was described. The
purification involved, (1) precipitation in a 40 % saturated solution of ammonium
sulphate, (2) binding to cysteine Sepharose and (3) binding to a dye affinity column.
Following this procedure 20-50 fig of protein was purified from 200 mL of bovine
blood. The purified fraction was visible with silver staining as a single band on SDS
polyacrylamide gels with a relative molecular mass of 45,000. The activity had been
purified 47,500 fold with a yield of 16 % of the total activity.
The cysteine dependent NAD'ase activity of the enzyme was extremely labile
and was present only in fresh preparations of bovine erythrocyte lysate. The
development of the successful purification strategy was dependent upon the
stabilisation of this labile activity. Several factors were found to be important to solve
this problem. One, the addition of 30 % ethylene glycol to all buffers following the
precipitation of the activity with ammonium sulphate. Two, the addition of protease
inhibitors 0.1 mM PMSF, 1 mM EDTA and 1 mM benzamidine HC1 at all stages of
the purification. Three, the minimisation of the time taken to purify the activity and
finally the removal of reducing reagents from the purified protein on storage of the
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enzyme at -16°C.
In chapter four the kinetic properties of the purified cysteine dependent
NAD'ase were compared to those of pertussis toxin. The mammalian enzyme had
approximately a 100 fold higher specific NAD'ase activity than pertussis toxin (1900
nmol of nicotinamide released min'kmg"1 of protein compared to 18 nmol.minkmg1).
The purified cysteine dependent NAD'ase also showed higher affinity for NAD+ (Km
value of 8 /xM compared to 30 fxM for pertussis toxin) and cysteine (Km value of
4 mM compared to 100 mM). Like pertussis toxin, the cysteine dependent NAD'ase
was inactive in the absence of reducing reagents and substrate kinetics were observed
only for cysteine containing a free thiol group and other amino acids could not be
substituted. Both enzymes had similar pH optimum curves measured at saturating
concentrations of substrates suggesting that they may have a common mechanism of
action. Evidence that cysteine was an acceptor for ADP-ribose was presented from
the separation of the reaction products of the cysteine dependent NAD'ase incubations
containing [3H-adenine]NAD+ on reverse phase HPLC. A tritium containing peak,
with an elution time of 5.5 minutes was observed only in incubations containing
cysteine and the cysteine dependent NAD'ase. The elution of this product between
ADP-ribose and NAD+ was consistent with it being ADP-ribose-cysteine. Treatment
of the putative ADP-ribosyl-cysteine product with phosphodiesterase released AMP
which confirmed the presence of mono-ADP-ribose in this product.
The ability of the cysteine dependent NAD'ase activity to ADP-ribosylate
protein was confirmed in chapter five. Enhanced labelling of a 55 kDa membrane
protein in bovine erythrocyte ghosts was observed. Unlike pertussis toxin, the
cysteine dependent NAD'ase was unable to modify G;a and was sensitive to inhibitors
ofpoly-ADP-ribosyltransferases and NAD'ases (thymidine and isoniazid respectively).
Evidence that mono-ADP-ribosylation of a cysteine residue on the target protein had
nonetheless occurred was presented. Firstly, the labelling was sensitive to pre-
treatment of the membranes with NEM; a sulphydryl alkylating reagent. Secondly,
the labelling was released by treatment with mercuric ion and was resistant to neutral
hydroxylamine. Thirdly, separation of the products of the treatment of labelled
protein with mercuric ion on ion exchange HPLC showed that the major product had
an elution time coincident with that of ADP-ribose. These results suggested that the
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cysteine dependent NAD'ase purified from bovine erythrocytes also had a novel
NAD+: cysteine mono-ADP-ribosyltransferase activity.
The strategy employed to purity the cysteine dependent NAD'ase has identified
an enzyme activity which in terms of its NAD'ase activity is similar to pertussis toxin
but which exhibits a novel NAD+: cysteine ADP-ribosyltransferase activity. ADP-
ribosylation of a 55 kDa protein in bovine erythrocytes has not been reported
previously. The methodologies developed for the purification, and the initial
characterisation of the kinetic properties and ADP-ribosyltransferase activities of this
enzyme form the ground work upon which a more detailed characterisation of the
enzyme and the target protein could be based.
6.3 Future Work
Further characterisation of the novel target protein was not feasible for this
present study, due to the constraints of time and expense of [32P-adenylate]NAD+.
Ideally confirmatory amino acid sequence would be obtained and a data base search
run to identify the target protein. Purification of the target protein would be required
to separate the enzyme and background labelled proteins; assuming that different
proteins of similar molecular weight are modified and not different sites on the same
protein. For example a two dimensional gel electrophoresis system could be
employed. Native ADP-ribosylated membrane proteins could be separated on the
basis of charge in the first dimension and denatured molecular weight in the second.
The separated protein could then be blotted onto polyvinylidene difluoride (PVDF)
membranes. The protein may be sequenced directly from this inert sequence
compatible membrane. If the protein was N-terminally blocked it may be digested in
situ with protease and the peptides separated on reverse phase HPLC182. If a known
protein of known function was identified from the target protein sequence, then the
presence of its activity in the erythrocyte ghost could be tested, and the effect of
ADP-ribosylation on the target protein assessed.
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An attempt to characterise the distribution of the enzyme was made by raising
antibodies against the cysteine dependent NAD'ase in mice. This proved unsuccessful
as the antibodies raised did not recognise denatured antigen on Western blots. This
work should be repeated. An alternative approach, involving the linking of the
antigen to a carrier, to increase the likelihood of success could be employed. The
antigen could be blotted onto nitrocellulose, and the nitrocellulose bound antigen then
used to immunise a mouse. The advantage of this approach would be that denatured
material from Western blotting could be used to raise antibodies, and therefore
increase the chances of reaction with the antigen after Western blotting.
An important advance in the understanding of the role of endogenous ADP-
ribosyltransferases could be made from the characterisation of the protein at the
molecular level. If the full amino acid sequence were known then better comparison
with the bacterial toxins could be made, and related proteins present in complex
systems may be identified, that otherwise would be difficult to identify enzymatically.
To do this amino acid sequencing of the N-terminal or of an internal peptide is
required. Oligonucleotide probes, coding for the identified sequence may then be
synthesised and used to screen a cDNA library in order to isolate the nucleotide
sequence coding for the enzyme activity.
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